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Differentiation of human pluripotent stem cells into pancreatic beta cells could lead to the 
development of clinically relevant cells for the treatment of pathologies of the pancreas, 
specifically type 1 diabetes, which is the most common reason for pancreatic transplantation. 
Type 1 diabetes is a disease that consists in damage of insulin producing β-cells, therefore 
impaired regulation of blood glucose levels. While a number of groups have reported generation 
of differentiated phenotypes from stem cells expressing Insulin, all of these protocols have been 
limited by low yield and lack of mature functional cell types.  
Organogenesis is a complex and dynamic process regulated by a milieu of chemical and physical 
signals along with interaction with neighboring cell types, all of which constitute the 
microenvironment niche of a developing organ. It is well recognized that in-vitro differentiation 
of embryonic stem cells can be best achieved by closely recapitulating the in-vivo micro-
environmental niche. However, such an effort towards concerted modulation of different micro-
environmental components is largely lacking in the area of pancreatic differentiation, where the 
primary focus till date have been on soluble chemical cues. We hypothesize that modulation of 
the chemical and physical micro-environment along with adequate intra-cellular signaling can  
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effectively modulate the functionality and fate commitment of differentiating population of stem 
cells. In order to test this hypothesis we developed strategies to alter physical properties of 
substrates, modify soluble signals during early stages of differentiation and use of novel 
intracellular signaling in pancreatic islet maturation. 
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1.0  INTRODUCTION 
1.1 THE PANCREAS 
Located beneath the liver and between the stomach and spine, the pancreas is a glandular 
organ that makes part of the human endocrine and digestive systems. The exocrine, or acinar part 
of the pancreas is composed of a system of ducts into which bicarbonate ions and digestive 
enzymes are secreted by centroacinar and basophilic cells respectively [1]. The endocrine portion 
of the pancreas, consisting of the islets of Langerhans, is responsible for production and secretion 
of an array of hormones whose main function is to regulate blood glucose levels. The islets of 
Langerhans are composed of several cell types, as illustrated in figure 1.1, each in charge of the 
production and secretion of a different hormone as follows: α cells produce glucagon, β-cells 
produce insulin, δ cells produce somatostatin and γ- cells produce pancreatic polypeptide [1].  
1.1.1 α-cells 
Alpha cells are make up to 20% of the endocrine pancreas and are responsible for 
production and secretion of glucagon. Upon low blood glucose levels, glucagon is secreted by α-
cells into the bloodstream. Glucagon binds to receptors on hepatocytes where a cascade of events 
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is initiated that results in activation of glycogen phosphorylase which hydrolyses glycogen into 
glucose in a process called glycogenolysis [1]  
1.1.2 β-cells 
β-cells are responsible for insulin production and release, therefore are the major 
contributor of blood glucose regulation. β-cells are the only cells in the body capable of 
synthesizing large amounts of insulin. Insulin is translated as a single chain inactivated 
preprohormone, preproinsulin, which during insertion into the endoplasmic reticulum gets 
cleaved into proinsulin.  Proinsulin consists of two domains connected by c-peptide, which gets 
cleaved by the action of several pancreatic endopeptidases, resulting in activated insulin and c-
peptide, which are then packaged into secretory granules by Golgi-apparatus and then released 
from the cell upon appropriate stimuli [2] 
Unlike most other cells in the human body, β-cells are capable of glucose intake in the 
absence of insulin. This is through GLUT2 transporters, which are transmembrane carrier 
proteins that allow passive transport of glucose into the cells [3]. Hence, when blood glucose 
levels are higher than intracellular levels, glucose diffuses into the β- cells trough GLUT2 
transporters. Once inside the cells glucose gets phosphorylated by glucokinase, converting 
glucose into glucose-6 phosphate [4]. Glucose-6-phospate is used during metabolic activities of 
the β-cells, releasing the phosphate group which then binds to ADP increasing the amount of 
ATP available for cell respiration. Increase in cellular respiration increases NAD(P)H 
concentrations and consequently shifts the cells to a oxidative status, which increases 
intracellular calcium levels and consequently causes the closing of potassium channels which 
leads to cell depolarization and insulin-containing vesicle release [5]. 
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1.1.3 δ-cells 
δ-cells are in charge of somatostatin production and release. Somatostatin is an inhibitory 
hormone that acts on a variety of organs and systems including the pituitary gland and the 
gastrointestinal system. Its action in the pituitary gland involves inhibition of release of several 
hormones including growth hormone and thyroid stimulating hormone. In the gastrointestinal 
systems it inhibits release of hormones including insulin and glucagon [6].  
 
Figure 1.1 General pancreas anatomy 
Exocrine cell interaction with the digestive system and endocrine cell (Islets of Langerhans) 
interaction with the blood stream. 
1.1.4 Pancreas development 
Pancreatic development starts with definitive endoderm (DE) formation which is marked 
by expression of several transcription factors including FOXA2, SOX17 and CER. Endoderm is 
formed by a flat sheet of cells which then folds forming the gut tube. Several signaling pathways, 
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including retinoic acid, fibroblast growth factors and TGFβ signaling, initiate specification of the 
pancreatic endoderm within the gut tube. Sonic hedgehog inhibition from the notochord induces 
expression of PDX1 in both the ventral and dorsal domain of the gut tube, although the sources 
of inhibition differ in each portion. This is followed by branching morphogenesis which will 
eventually form endocrine cells, duct cells and acinar cells. These events happen in both dorsal 
and ventral portions of the pancreas although the timing is different for each portion, with the 
dorsal development being more rapid than the ventral portion. Eventually rotation of the gut tube 
brings both compartments together and organization of the exocrine portion into acini and of the 
endocrine portion into islets occurs. At birth, the pancreas is capable of producing insulin, 
although glucose responsiveness differs from that seen in adult pancreas having a lower release 
threshold. Normal glucose stimulated insulin release is achieved within few days of birth [7,8].  
1.1.5 Pancreatic disorders 
Pancreatic disorders can be catalogued into two categories depending on which portion of 
the pancreas they affect. The main diseases that affect the exocrine portion of the pancreas are 
pancreatitis and pancreatic cancer, while diabetes mellitus is the ailment affecting the islets of 
Langerhans.  
1.1.5.1 Exocrine disorders 
The most common diseases affecting the exocrine portion of the pancreas are pancreatitis 
and pancreatic cancer. In pancreatitis, inflammation of the pancreas occurs due to injury caused 
by action of digestive enzymes on pancreatic tissue. Normally these enzymes are activated once 
they exit the pancreas, however, blockage due to infection or gallbladder stones amongst other 
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reasons can cause accumulation and activation within the pancreas. Depending on the causes, 
pancreatitis can be acute or chronic. Chronic pancreatitis is commonly caused by alcohol abuse, 
cystic fibrosis and hypercalcimia. In such cases, permanent damage to pancreatic structures takes 
place and could lead to grave complications including development of diabetes [9].  
The majority of pancreatic cancer cases are classified as ductal adenocarcinomas which 
affect the exocrine potion of the pancreas. This cancer is characterized by poorly differentiated 
glandular structures believed to arise from progressive tissue changes. Prognosis of the disease is 
poor with a 1 year survival rate of 25%. Treatment options include surgery, chemotherapy and 
radiation, however, detection usually occurs late during the disease progression, therefore 
treatment success is limited. Current research in the area of pancreatic cancer is focused on early 
detection methods [10]. 
1.1.5.2 Diabetes Mellitus  
Diabetes mellitus is a family of diseases that affect the endocrine portion of the pancreas, 
specifically, β-cells. It can be categorized into type 1 diabetes and type 2 diabetes according to 
their mechanism of action, even though type 2 diabetes itself is a whole family of disorders 
caused by an array of different factors [11].  
Type 2 diabetes is often referred to as insulin resistant diabetes. It accounts for 90% of 
diabetic cases in the US and while there is a genetic component to it, it is highly linked to 
environmental factors such as sedentary life-style and at early stages can be treated through good 
nutrition and exercise. In a lot of cases type 2 diabetic patients produce normal or even elevated 
levels of insulin, however, it is the target tissues that are not able to properly use insulin, 
therefore uptake of glucose into the cells is delayed and decreased [12]. Although the exact 
mechanisms by which cells diminish their response to insulin are unclear, glucotoxicity, or cell 
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damage due to hyperglycemia is thought to be a key player in this [13].  Exercise usually 
reverses this insulin resistance due to the fact that skeletal muscle does not need insulin for 
glucose uptake, therefore normoglycemia is restored and this increases insulin responsiveness 
from cells throughout the body [14]. Unfortunately, type 2 diabetes patients often fail to make 
lifestyle changes leading to progression of the disease which often results in β-cells destruction 
and therefore exogenous insulin dependence.  
Type 1 diabetes on the other hand is an autoimmune disorder prompting the destruction 
of β-cells and caused by genetic pre-disposition and often developing after viral infections. It is 
commonly diagnosed during childhood and leads to a series of systemic complications including 
cardiovascular system, kidneys, nerves and eyes. Since β-cells are destroyed in type 1 diabetes, 
insulin production is diminished and treatment options involve exogenous insulin supply [2].  
During type 1 diabetes, glucose uptake from cells is impaired due to lack of available 
insulin, therefore cells need to find alternative ATP sources through breakdown of proteins from 
skeletal muscle, fatty acid breakdown from adipose tissue, and conversion of glycogen into 
glucose from the liver. Protein breakdown results in transport of amino acids to the liver, fat 
metabolism results in ketone conversion and glycogenolysis results in further elevated blood 
glucose levels, all of which have detrimental effects such as hypoxia and acidosis [12].  
1.1.6 Therapeutic approaches for diabetes 
As mentioned in the previous section, the first therapeutic option for type 2 diabetes 
consists of life-style changes such as exercise. In most cases however, poor patient compliance 
leads to need for pharmacological intervention such as drugs that inhibit digestion of 
carbohydrates, decrease glucose production in the liver, make tissues more responsive to insulin 
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or increase insulin secretion. In advanced cases where β-cell destruction occurs, insulin supply is 
necessary [15].  
The main treatment option for type 1 diabetes consists of exogenous insulin supply. 
Along with this, constant glucose monitoring is necessary due to the fact that high glucose could 
lead to the events outlined in the previous section which could result in diabetic coma and 
possibly death; however, overuse of insulin could result in a hypoglycemic event leading to 
diminished glucose transport into the brain which could cause permanent brain damage and even 
death [12]. The complexity of this type of treatment has led investigators to develop alternative 
options for the treatment of diabetes in which beta cells are either repaired or replaced leading to 
endogenous production of insulin by the body.  
The main alternative treatment is pancreatic transplantation which can be done alone or 
with kidney depending on the kidney function of the diabetic patient. Donor tissue comes from 
cadaveric patients, therefore the main limitation to this alternative is availability; hence the 
procedure is only performed in severe diabetes cases where insulin supply is deemed ineffective 
and there is permanent kidney damage [16]. A less invasive transplantation alternative involves 
infusion of isolated islets into the portal vein followed by immune suppression. In cases where 
this procedure is done, one patient may require islets from up to 3 donors, which makes this 
alternative highly restrictive due to availability [17].  
Due to the limitations of current treatments, and high prevalence of diabetes, finding 
alternative cell sources for transplantation has been a prominent area of research in recent 
decades. Stem cells have received considerable attention in this regard and have shown 
promising potential as an alternate cell source. Differentiation of stem cells toward insulin-
producing β cells has been attempted following approaches to recapitulate the natural process of 
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development. This change can be achieved by closely mimicking the native microenvironment, 
most commonly through the addition of soluble growth factors and molecules that direct 
differentiation [18]. A schematic of multi-stage protocols for differentiation of pluripotent stem 
cells into pancreatic cells, along with commonly used molecules and growth factors is 
represented in Figure 1.2 
 
Figure 1.2 Schematic representation of multi-stage protocols for differentiation of pluripotent stem 
cells into pancreatic cell, along with commonly used molecules and growth factors 
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1.2 SPECIFIC AIMS 
Diabetes is a disease affecting over 20 million people in the US. In diabetic patients the 
body is unable to produce or properly use insulin, which is necessary for intake of glucose into 
the cells, hence affecting cells’ ability to produce energy [19]. The most common treatment for 
type I diabetes consists of exogenous insulin supply which can lead to grave complications, 
including a hypoglycemic event which often leads to death. While transplantation of pancreatic 
islets offers potential therapy, it is restricted by scarcity of donor islets[20]. Human embryonic 
stem cells (hESC) have two characteristics that make them an attractive alternative to whole 
organ transplantation: they can be maintained and expanded in an undifferentiated state 
indefinitely and can potentially be coaxed to differentiate into any cell type which makes them a 
possible unlimited cell source for transplantation[21]. Given these, it is no surprise that 
pancreatic differentiation of mouse and hESC has received considerable attention over the last 
decade. However exploitation of the full potential of embryonic stem cell requires a robust 
protocol for generation of mature and functional cell types, followed by efficient scaffold for 
transplantation 
A number of groups have developed differentiation protocols that successfully derive 
insulin-expressing cells, however, several of these protocols have several limitations including 
low yield of insulin expressing cells, improper maturation, and therefore lack of functionality 
[22]. Most existing protocols exploit modulation of known developmental pathways trough 
chemical cues such as growth factors and small molecules [23]; however, other aspects of the 
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developmental niche have been ignored thus far, including physical and mechanical cues as well 
as cross-talk with different cell types of relevance to organogenesis. 
Our long term goal is to develop a protocol for differentiation and transplantation of ESC 
into insulin producing and glucose responsive cells for treatment of type I diabetes. We propose 
to do this by emulating different aspects of the native microenvironment, chemically modulating 
previously identified contributing pathways as well as mimicking interactions with other cell 
types. This approach can reveal novel attributes of cell-material interactions along with cell-cell 
interaction. The project will enhance our understanding of how cells interact with their 
microenvironment during the process of differentiation. Furthermore, while we are specifically 
targeting pancreatic maturation a similar strategy can be adopted for other organ specific 
maturation as well.   
The stem cell niche is the 3D microenvironment that stem cells encounter in the body and 
it composed of physical, chemical and mechanical cues that ultimately regulate cell fate [24]. 
This study aims to demonstrate how each of these microenvironmental components can be 
modulated to achieve hESC differentiation into cells with the potential of being used as an 
alternative cell source for the treatment of diabetes and other pathologies that affect the pancreas. 
In this study we use modulations of a different aspect of the microenvironment at different stages 
of differentiation as a possible strategy for induction as follows: 
(a) Substrate physical properties to induce endoderm differentiation 
(b) Novel use of intracellular signaling in pancreatic islet maturation 
(c) Modulation of early germ layer commitment to alter functional phenotype 
(d) Unique use of bioinformatics tools to analyze differentiation strategies   
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1.2.1 Aim 1: To evaluate the effect of substrate physical properties in early germ layer 
commitment 
Conventionally, ESCs are differentiated by altering their chemical microenvironment 
through growth factors/ inhibitors/ inducers. Recently however, it was established that a 
mechanical microenvironment can also contribute towards cellular phenotype commitment [25]. 
In Chapter 2 we investigate how the cellular mechanical microenvironment of substrates affects 
the differentiation and phenotypic commitment of ESCs by culturing cells in a fibrin hydrogel 
matrix in 2D and 3D cultures.  
1.2.2 Aim 2: To evaluate the effect of soluble growth factors on pancreatic maturation of 
hESCs 
It is well understood that potential for functional maturation of the ESCs is strongly 
dependent on the quality of initial germ layer commitment, in our case endoderm germ layer. 
Past studies have established multiple pathways of inducing DE. However, the effect of pathway 
of endoderm induction on late stage functional maturation still remains elusive. The objective of 
the Chapter is to quantitatively analyze the effect of alternate DE induction pathways on the 
dynamics of differentiation and functional maturation to pancreatic islet cell-types.  
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1.2.3 Aim 3: To  investigate the effect of cell-cell signaling during pancreatic maturation 
of hESC 
Existing β-cell differentiation protocols typically achieve later stages of maturation 
through addition of chemical cues that modulate pathways known to induce maturation of β-cells 
in-vivo. Our objective in Chapter 4 is to investigate the effect of cell-cell interaction in inducing 
maturation of hESC derived pancreatic progenitor cells to islet cell types. We chose endothelial 
cells as a possible candidate since during organogenesis endothelial cells from the aorta develop 
in close proximity to the pancreas and has been implicated to be involved in islet development 
[26,27]. Furthermore, endothelial cells have been proven to increase survival and functionality of 
β-cells in culture and have been proven to modulate differentiation of other tissues including 
endodermally derived tissues.  
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2.0  INDUCING ENDODERM DIFFERENTIATION BY MODULATING 
MECHANICAL PROPERTIES OF SOFT SUBSTRATES  
2.1 INTRODUCTION 
ESC are pluripotent cells isolated from the inner cell mass of the blastocyst. Aside from 
their ability to differentiate into any tissue cell type, they can be propagated in vitro in an 
undifferentiated state indefinitely which makes them perfect candidates for use in the area of 
regenerative medicine and study of differentiation [21]. The first stage of ESC differentiation is 
marked by the formation of 3 germ layers with distinct molecular markers from which all tissue 
types will arise. Ectoderm forms mainly the skin and the nervous system. The mesoderm forms 
muscle, cartilage, bone as well as hematopoietic cells while endoderm mainly forms the GI tracts 
and both liver and pancreas [28]. 
Research in the last decade has established the possibility of differentiating ESCs in an 
in-vitro setting to not only early germ layers, but to mature organ specific cells as well. Most of 
these in-vitro inductions are achieved through modulations of the chemical microenvironment.  
More recently, researchers are studying the effect of mechanical cues such as matrix elasticity on 
stem cell differentiation [29,30]. Mesenchymal stem cells, when cultured on substrates of 
varying stiffness were reported to exhibit significant difference in their lineage commitment, 
which could be correlated to the physiological stiffness of the differentiated phenotype [25]. 
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Similar studies have been performed in ESC; however, most of these studies are targeted toward 
osteogenic differentiation, hence using substrates with stiffness ranges that are a few orders of 
magnitude higher than the ones used for this study [30].  
In this study, we are reporting how the physical microenvironment of soft substrates 
affects the early differentiation and phenotypic commitment of ESC, with emphasis on 
endodermal differentiation.  In order to demonstrate this effect, fibrin, a biocompatible hydrogel 
was selected as the substrate for providing the desired variation in the physical 
microenvironment, primarily by modification of its gelation characteristics. Fibrin was selected 
primarily because of its known attributes as a biocompatible and biodegradable scaffold, which 
will enable future translation into clinical studies. Furthermore, fibrin is a biopolymer that plays 
a key role in the natural process of wound healing [31] which makes it a good candidate for stem 
cell transplantation [32]. Moreover, it has also been recently studied as a gel carrier system for 
beta-islet transplantation [33] and can also be easily coupled with chemical cues to aid 
differentiation [34], making it ideal for stem cell differentiation studies. Additionally, the 
substrate chemistry of fibrin hydrogels can be easily manipulated to achieve a broad range of soft 
substrates, making it suitable for the present study. 
The overall objective of this study is to investigate the effect of physical properties of soft 
substrates on specific characteristics of ESC. The ESC cultures differentiated on fibrin gel were 
analyzed in detail to ascertain their proliferative potential and differentiation patterning behavior 
in response to variations of substrate mechanical properties. Two different culture configurations 
were analyzed: cells seeded on top of pre-formed fibrin gel (2 dimensional) and cells embedded 
inside the fibrin gel (3 dimensional). To the best of the authors’ knowledge this is the first report 
illustrating the effect of physical properties of soft substrates on endodermal differentiation of 
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ESC. This can have a significant impact in the derivation of hepatic or pancreatic cells from 
ESCs, to be used in the treatment of hepatic disorders and diabetes respectively. 
2.2 RESULTS 
2.2.1 SEM characterization of fibrin microstructure  
Appropriate characterization of ESC interaction with a substrate microenvironment 
requires a thorough understanding of the microstructural features of the substrate under various 
conditions. Figure 2.1A and 1B illustrate SEM images of the fibrin gels taken at two very high 
values of fibrinogen concentrations of 1 and 8mg/ml, respectively selected as representative 
concentrations. It was observed that for a fixed fibrinogen concentration, there was a decrease in 
fiber diameter as thrombin concentration increased (Figures. 2.1A: a, b, c) and the fibers 
appeared to be less bundled. It can also be seen that there was no significant difference in fiber 
diameter between 1x and 2x compared to 0.25x. The difference in diameter also appeared to 
become less significant as fibrinogen concentration increased. 
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Figure 2.1: Microstructure of fibrin gels of varying fibrinogen thrombin concentrations.  
(A) Effect of varying fibrinogen concentration as well as fibrinogen to thrombin ratios on the 
microstructure of the gels imaged at a high magnification of 20KX. In (a)-(c) 1 mg/ml of fibrinogen at 
fibrinogen to thrombin ratios of 0.25X, 1X, and 2X respectively. In (d)-(f) 8 mg/ml of fibrinogen at fibrinogen 
to thrombin ratios of 0.25X, 1X, and 2X respectively. (B) Effect of varying the fibrinogen concentration as 
well as the fibrinogen to thrombin ratios on the microstructure of the gels observed at a low magnification of  
5KX. In (a)-(c) 1 mg/ml of fibrinogen at fibrinogen to thrombin ratios of 0.25X, 1X, and 2X, respectively. In 
(d)-(f) 8 mg/ml of fibrinogen at fibrinogen to thrombin ratios of 0.25X, 1X, and 2X, respectively. 
As fibrinogen concentration decreased for a fixed fibrinogen to thrombin (F/T) ratio, the 
fibers formed more bundle type thicker structures, as can be seen in Figure 2.1A: e compared to 
1A: b. As a result, each fibril appears to have a larger fiber diameter: ~ 0.5-0.75 mm for 1mg/ml 
fibrinogen compared to~0.1 mm for a fibrinogen concentration of 8mg/ml at a fixed F/T ratio 
of 1x.  
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Table 2.1 Concentration of Thrombin in NIH units for all fibrin hydrogel conditions 
 
Furthermore, at a fixed fibrinogen concentration, the substrate appeared to have a more 
open pore structure with a larger pore size as thrombin concentration decreased from 2x to 1x 
and 0.25x, as can be seen for both 1 and 8mg/ml fibrinogen concentrations in Figures 2.1B: a-c 
and d-f, respectively. To better analyze the effect of thrombin concentration on the porosity of 
the substrate, ImageJ software was used to quantify the average pore size of the gel at fixed 
fibrinogen concentrations. SEM images were binary and ImageJ software was used to estimate 
the average size of spaces between fibers. This value was obtained for each fibrinogen 
concentration and was normalized to the values obtained for gels synthesized with the same 
fibrinogen concentration at a F/T ratio of 2x. As illustrated in Figure 2.2, pore size decreased 
with increasing thrombin concentrations for both 1 and 8 mg/ml values of fibrinogen 
concentrations. However, the effect of thrombin concentration on pore size was much stronger 
between 0.25x and the higher ratios, while between 1x and 2x, the changes were minimal as can 
be seen in Figure 2.1. 
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Figure 2.2: Average pore size  
calculated using ImageJ for 1 mg/ml and 8 mg/ml fibrinogen concentrations and all three fibrinogen to 
thrombin ratios normalized to 2X for both fibrinogen concentrations. * p<0.05 compared to highest stiffness 
group. 
2.2.2 Rheological characterization of fibrin hydrogels  
The effect of microstructural variations of the gel on the macroscopic property of the gel 
substrate was investigated by conducting a rheological characterization of the gel. Table 2 
illustrates the storage modulus (G’), a measure of energy stored by the sample under oscillatory 
deformation conditions, while Table 3 illustrates the loss modulus (G”), a measure of energy 
dissipated under vibratory conditions. Both storage and loss moduli showed little dependence on 
frequency of oscillation, indicative of a solid-like behavior: therefore, their values at a frequency 
of 0.5Hz was arbitrarily chosen as a representative value.  
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After being cleaved by plasmin, fibrinogen is converted into the monomeric form of 
fibrin and self-assembles to form an insoluble fibrin clot that is stabilized by the crosslinking of 
factor XIII. In the current study, the scaffold storage modulus was varied by two orders of 
magnitude from 4 Pa, corresponding to a fibrinogen concentration of 1mg/ ml, and an F/T ratio 
of 0.25x to 247 Pa, corresponding to a fibrinogen concentration of 8mg/ml and an F/T ratio of 
2x. Furthermore, upon increasing thrombin concentration for a fixed fibrinogen concentration, 
gel stiffness increased by as much as 76 Pa (8mg/ml of fibrinogen for F/T ratios of 0.25 and 2x). 
Mechanical stiffness was varied by either keeping the fibrinogen concentration fixed or by 
selecting four different fibrinogen concentrations: 1mg/ml representing the low range and 
8mg/ml representing the high range. Similarly, for a fixed fibrinogen concentration, the thrombin 
concentration was varied correspondingly to F/T ratios of 0.25, 1 and 2x, representing low, 
medium and high units of thrombin, respectively. Based on this, rationale, it was thus possible to 
prepare fibrin gels that exhibited a wide range of mechanical stiffness.  
Moreover, despite altering the F/T ratio, conditions with the same thrombin concentration 
and different fibrinogen concentrations also existed. Similarly, after increasing fibrinogen 
concentration, gel stiffness also increased by as much as 95 Pa (4mg/ml fibrinogen with F/T 2x 
and 8mg/ml fibrinogen with F/T 1x). The three cases in which fibrinogen concentration was 
doubled were as follows: 1) 1mg/ml fibrinogen with an F/T ratio of 2x and 2mg/ml of fibrinogen 
with an F/T ratio of 1x; 2) 2mg/ml of fibrinogen with an F/T ratio of 2x and 4mg/ml of 
fibrinogen with an F/T ratio of 1x; and 3), 4 mg/ml of fibrinogen with an F/T ratio of 2x and 8 
mg/ml of fibrinogen with an F/T ratio of 1x). Gel stiffness nearly doubled in all three cases, 
while thrombin concentration remained fixed except at low fibrinogen concentrations as 
illustrated in Table 2. 
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Table 2.2: G’ values in Pa for various fibrinogen concentrations and all crosslinking conditions at a 
frequency of 0.5 Hz 
 
Table 2.3: G’’ values in Pa for various fibrinogen concentrations and all crosslinking conditions at a 
frequency of 0.5 Hz 
 
In comparing this trend where thrombin concentration was doubled for a fixed fibrinogen 
concentration (1-2x for all fibrinogen concentrations), a much lower relative increase in storage 
modulus was observed, except at lower fibrinogen concentrations. This suggests that fibrinogen 
concentration was more influential on the manipulation of gel moduli, except under dilute 
conditions. Interestingly, the storage modulus for all conditions was not exclusive and an overlap 
in modulus was observed between the two conditions. More specifically, the moduli of gels 
prepared with 1mg/ml fibrinogen and an F/T ratio of 1x and 2mg/ml fibrinogen with an F/T ratio 
of 0.25x were both~14 Pa, indicative of the influence of other microstructural forces affecting 
mechanical stiffness such as fiber diameter, porosity and orientation. 
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2.2.3 Effect of substrate stiffness on embryonic stem cell proliferation 
ESCs plated on soft fibrin substrates were found to attach well under all substrate 
conditions and were alive and proliferating. However, cells did not spread out significantly and 
retained a spherical clumped-up morphology.  
Observation of the cells after three days of culture consistently showed the formation of 
cell clusters (Figure 2. 3). When cell morphology was compared across substrates of different 
thrombin concentrations for the same fibrinogen concentration, it was typically observed that 
substrates with lower thrombin concentrations resulted in larger cell clusters compared to their 
more crosslinked counterparts. 
 
Figure 2.3: Aggregation of cells on fibrin substrates.  
Representative images of cells plated on gels of identical fibrinogen concentration, but varying cross-
linking fibrinogen/thrombin ratio: 0.25X (Left) and 2X (Right). Cells attach, but do not spread out, instead, 
they form cell clusters. Cell cluster size greater in gels with lower cross-linking ratio.  
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Since differences in cell cluster size can be attributed to differences in cell proliferation 
rate, proliferation analysis was performed by Alamar blue assay 24 h after plating the cells on 
fibrin gels. A duration of 24 h was chosen primarily to minimize the effect of fibrin degradation 
by the cells and to avoid the effect of differentiation on proliferation. The effect of thrombin 
concentration of the substrates on cellular proliferation is illustrated in Figure 2.4. For each 
fibrinogen concentration, the proliferation rate was normalized to the condition with the lowest 
F/T ratio. It was consistently observed that for a specific fibrinogen concentration, ESCs cultured 
on lower crosslinked substrates exhibited a higher proliferation rate compared to parallel cultures 
on a more crosslinked structure. 
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Figure 2.4: ES cell proliferation on fibrin substrates of varying compositions 
Comparison of the proliferation of mouse ES cells plated on gels of different fibrinogen 
concentration and varying cross-linking ratio after 24 hours of plating. Y-Axis represents alamar blue 
fluorescence. All results normalized with respect to the lowest cross-linking ratio for each group. At all 
fibrinogen concentrations proliferation was found to decrease as the  cross-linking increased. * p<0.05 
compared to highest stiffness group. 
2.2.4 Effect of substrate physical properties on embryonic stem cell differentiation 
2.2.4.1 Substrate Stiffness  
ESCs were plated on the gels and allowed to spontaneously differentiate for five days, 
after which samples were analyzed by qRT-PCR for three different marker for each of the germ 
layers and for pluripotency assessment. The markers used were: undifferentiated markers REX1, 
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OCT4 and SOX2 [35-37]; early endoderm markers AFP, SOX17 and HNF4 [38-40]; early 
mesoderm markers BRACH, GSC and FGF8 [41-43]; and early ectoderm markers Nestin, FGF5 
and BMP4 [44-46]. During differentiation, cells were cultured in DMEM/FBS without further 
lineage specific induction.  
The effect of substrate properties on ESC differentiation was analyzed by comparing the 
relative variation of all germ layer markers across the entire range of substrate stiffness. 
Figure 2.5A illustrates the sensitivity of each germ layer along with pluripotency to changes in 
substrate stiffness. It was observed that pluripotency markers maintained similar expression 
levels in all substrates. As to individual germ layers, Figure 2.5A shows that mesoderm and 
ectoderm markers were relatively insensitive to changes in substrate stiffness in the specific 
stiffness ranges examined. Endoderm markers, however, were found to respond strongly to 
changes in substrate properties. It was observed that substrates of lower stiffness of~13 Pa 
resulted in stronger endoderm upregulation. However, a higher stiffness range of 171 Pa was 
observed to upregulate both AFP and SOX17. Interestingly, the other germ layers were also 
slightly elevated under higher stiffness conditions, indicating an overall increase in 
differentiation under those conditions. Moreover, preferential upregulation of endoderm markers 
was observed only at lower stiffness conditions. Of the endoderm markers, the magnitude of 
upregulation of AFP was thousands of folds stronger than that of SOX17, while both SOX17 and 
AFP elicited a similar trend in expression.  
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Figure 2.5: The effect of changing substrate stiffness on the ESC differentiation  
in 2-dimensional (a) and 3-dimensional (b) configurations. Results are normalized with respect to 
undifferentiated cells. Most significant effect was observed in the up-regulation of endoderm markers SOX17 
and AFP in lower range stiffness gels. Effect was more prominent in 3-dimensional configurations. 
2.2.4.2 Substrate Composition 
As earlier mentioned, fibrin substrate properties were modified by changing both 
fibrinogen concentration and F/T ratio. As a result, it was important to analyze the effect of gel 
composition on stem cell differentiation. Differentiation patterns were compared across different 
thrombin concentrations for a fixed value of fibrinogen concentration (Figures 2.6a, b). Very 
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high fibrinogen concentrations of 1 and 8mg/ml were chosen to assess differentiation patterns 
across a wide spectrum of fibrinogen concentrations. For ease of comparison, the fold changes in 
gene expression levels were represented by normalizing to 2x crosslinking for each fibrinogen 
concentration. 
 
Figure 2.6: The effect of substrate cross-linking ratios on 2D ESC differentiation 
analyzed at  extreme fibriniogen concentrations of 1mg/ml (a) and 8mg/ml 1mg/ml (b) in 2-dimensional 
configuration. Results are normalized with respect to highest cross-linking ratio of 2X. Most significant effect 
was observed in the up-regulation of endoderm markers when compared between cells differentiated on gels 
of lower cross-linking (0.25X, 1X) and higher cross-linking (2X) ratio. * p<0.05 compared to highest stiffness 
group. 
Analogous to Figure 2.5, the mesoderm and ectoderm markers were found to be 
relatively insensitive to changes in crosslinking ratio in the 1mg/ml fibrinogen concentration 
(Figure 2.6a). In contrast, the endodermal markers, particularly SOX17 and AFP, were found to 
be extremely sensitive to changes in crosslinking ratio. For 1mg/ml fibrinogen concentration, we 
observed approximately 5- and 9-fold increases in AFP expression levels for softer gel 
conditions of ratios 0.25 and 1x, respectively, compared to the stiffer gels synthesized at 2x. 
SOX17 expression levels exhibited a moderate 3- and 5-fold increase when thrombin 
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concentration was lowered from 2 to 1x in both fibrinogen concentration groups, respectively. 
Similar patterns were found across all fibrinogen concentrations, where lowering the crosslinking 
ratio resulted in stronger expression of endoderm markers (Appendix figs. 2.1, 2.2). 
While the above analysis focuses on the effect of changing crosslinking ratios for fixed 
fibrinogen concentrations, it was worthwhile to compare the effect of changing fibrinogen 
concentrations for a fixed cross-linking ratio, since both cases resulted in differences in substrate 
stiffness (Table 2.2). Figure 2.9 represents the changes in gene expression levels when the F/T 
ratio remained constant (1x) while the concentration of fibrinogen varied between 1 and 8 mg/ml 
(Figure 2.9A). It was observed that lower values of fibrinogen concentration preferentially 
favored endoderm differentiation. 
2.2.4.3 Substrate Microstructure 
In all analyses, we consistently observed that endoderm upregulation correlated with 
lower substrate stiffness conditions and was achieved either by lowering the crosslinking ratio 
for fixed fibrinogen concentrations or by lowering fibrinogen concentrations for a fixed 
crosslinking ratio. To further analyze whether substrate stiffness was uniquely controlling the 
differentiation patterning, we examined two fibrin substrates of similar stiffness but of various 
fibrinogen and thrombin concentrations and analyzed ESC differentiation patterns on them. As 
illustrated in Tables 2.1 and 2.2, gels synthesized with 1mg/ml fibrinogen with an F/T ratio of 1x 
and 2mg/ml fibrinogen with an F/T ratio of 0.25x resulted in a similar gel stiffness value of~14 
Pa. ESCs differentiated on these two conditions were analyzed for their differentiation patterns, 
as illustrated in Figure 2.10. Of interest, it was observed that the mesoderm and ectoderm 
markers elicited quite similar behavior under these conditions, although endoderm markers were 
strongly altered. These results indicate that while substrate stiffness strongly influenced 
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differentiation patterns, it was clearly not the sole player in this complex process. Careful 
observation of the fibrin gel under these two conditions by SEM (Appendix figure 3) revealed 
significant differences in their microstructural characteristics despite comparable stiffness values. 
Analysis revealed that some of the major structural differences included differences in fiber 
density, fibrin and pore size. Following this analysis, it is reasonable to suggest that along with 
macroscopic stiffness, microstructural features are also likely to influence differentiation 
patterns. A more detailed characterization of the gel microstructural features and its possible 
correlation with ESC differentiation is currently being investigated by our group.  
2.2.4.4 Culture Configuration  
Experiments were performed by plating cells on pre-formed fibrin gels in 2D 
configurations. However, to better elucidate the effects of stiffness, composition and 
microstructure in ESC differentiation, ESCs were also cultured in 3D configurations in which 
ESCs were suspended within the fibrin substrate during synthesis of the gels.  
Similarly to 2D experiments, the effect of substrate properties on ESC differentiation was 
analyzed by comparing the relative variation of all germ layer markers across the entire range of 
substrate stiffness. Figure 2.5B illustrates the sensitivity of each germ layer along with 
pluripotency to changes in substrate stiffness. Pluripotency, mesoderm and ectoderm markers 
were relatively insensitive to changes in substrate stiffness in the specific stiffness ranges 
considered in this study. Endoderm markers were found to respond strongly to changes in 
substrate property. It was observed that substrates of lower stiffness (~ 13 Pa) resulted in 
stronger endoderm upregulation. In contrast to 2D configurations, the positive effect of higher 
stiffness range was less obvious in 3D cultures, where the strongest effect was in the lower range 
of 13 Pa. Both SOX17 and AFP elicited a similar trend in expression; the magnitude of 
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upregulation of AFP was thousands of folds stronger than that of SOX17, with the upregulation 
under 3D culture being more dominant than 2D configuration. An additional control of ESC 
differentiation through EB formation was included in the 3D cultures to account for the possible 
effect of biochemical induction arising from differential swelling of the gels. As illustrated in 
Figure 2.5, the magnitude of upregulation in softer substrates was much stronger than that of EB, 
which suggests that the substrate played a more significant role than biochemical induction 
through the media. 
We also studied the effect of substrate composition in 3D configurations (Figure 2.7). 
When the fibrinogen concentration was maintained constant and thrombin ratios were varied, the 
3D culture resulted in a much stronger effect on SOX17 expression levels, which was 
upregulated by 3- and 7-fold for gel conditions of 0.25 and 1x respectively, compared to the 
stiffer gels synthesized at 2x for the 1mg/ml fibrinogen gels. In the case of the 8mg/ml gels, an 
even more pronounced effect was found with 5- and 15-fold upregulation in the 1 and 0.25x 
conditions, respectively. Furthermore, in the 8mg/ml fibrinogen conditions, the endoderm marker 
HNF4 also exhibited a significant upregulation comparable to SOX17. Additionally, while the 
2D cultures led to somewhat elevated expression levels of many of the germ layer markers, 3D 
cultures were consistently more specific for endoderm markers along with FGF and Nestin. 
Hence, while the overall effect of softer substrate (~ 13 Pa) was more pronounced than the stiffer 
substrates, lower crosslinking always resulted in stronger endoderm expression compared to 
higher crosslinking for invariant fibrinogen concentrations in the entire range of substrate 
stiffness considered in this study. 
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Figure 2.7: Effect of  substrate crosslinking ratios on 3D ESC differentiation  
analyzed at extreme concentrations of 1 mg/ml (a) and 8 mg/ml 1 mg/ml (b).  Results are normalized to 
highest crosslinking ratio of 2x. Most significant effect was observed in the upregulation of endoderm 
markers compared to cells differentiated on gels of lower crosslinking (0.25x, 1x) and higher crosslinking (2x) 
ratios. * p<0.05 compared to highest stiffness group. 
 To further analyze the differentiated cell population for its protein expression levels, 
immunohistochemical analysis was performed for the case eliciting the strongest upregulation in 
gene expression: the 3D culture for SOX17 and AFP expression. As illustrated in Figure 2. 8, the 
differentiated cells cultured in the softer substrates that resulted in highest upregulation of both 
AFP and SOX17 (1mg/ml, 1x) stained strongly for both SOX17 and AFP. High co-expression of 
these markers was also observed in the cell clusters formed. Parallel analysis of differentiated 
cells on gels of higher thrombin concentrations of 2x showed negligible stain (data not included). 
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Figure 2.8: Immunocytochemistry images of endoderm markers  
For cells  plated at 1 mg/ml and 1x. High expression of endoderm markers AFP (Red) and Sox17 (Green) was 
observed in the cell clusters that were found to be highly co-expressed 
When crosslinking ratios were maintained constant and fibrinogen concentrations were 
modified, we once again found that lower values of fibrinogen concentration (Figure 2.9b) 
preferentially favored endoderm differentiation and this effect was more accentuated in the 3D 
culture compared to the 2D culture, with upregulation of endoderm AFP and SOX17 being 4 and 
17x higher in 1mg/ml fibrinogen gels, respectively. 
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Figure 2.9: Pluripotency and germ layer markers of ESC cells differentiated in substrates of various 
fibrinogen concentrations with same crosslinking ratios  
 (A) 2D and (B) 3D cultures. Significant upregulation of endoderm markers was found when cells were 
differentiated on gels obtained at lower fibrinogen concentrations. * p<0.05 compared to highest stiffness 
group. 
2.3 DISCUSSION 
In this paper we present an analysis of the effect of mechanical microenvironment on the 
embryonic stem cell (ESC) culture and differentiation. ESCs were maintained on soft fibrin 
substrates of varying physical characteristics, modulated by altering both of its components – 
fibrinogen and thrombin involved in the formation of fibrin gels. 
Analysis of the microscopic architecture of the fibrin gels using SEM reveal a strong 
effect of both fibrinogen concentration and crosslinking on fiber diameter, fiber bundling and 
relative pore size, as demonstrated in Figures 2.1 and 2.2. Such findings are in agreement with 
previously published data [47,48]. Mechanical characterization of the fibrin gels was performed 
using plate rheometer to measure both the storage and loss modulus as summarized in Table 2.2. 
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In comparing Table 2.2 and 2.3, it should be noted that G’>>G” for all of the samples considered 
which suggests as expected a more solid-like than liquid-like behavior for all the conditions 
consistent with low loss characteristics of the solids. The results illustrate that increase in 
fibrinogen or thrombin concentration results in an increase in substrate stiffness. While a higher 
response is observed by increasing the fibrinogen concentration, chemical variation is also 
greater, which lead us to focus on the effects of varying thrombin concentration for most of our 
observations.  
The ESCs were cultured for 5 days on these substrates, at the end of which the cells were 
analyzed for their proliferative and differentiation potential. Since we are interested in early germ 
layer commitment, differentiation was performed over a relatively short period of time. Our first 
observation after cell plating was that instead of spreading out, the cells form clusters which vary 
in size depending on the thrombin concentration, as seen in Figure 2.3.  An explanation can be 
that the fiber thickness decreases as the substrate becomes more cross-linked, thus decreasing 
pore size, and exhibiting a higher modulus as shown in Figures2.1 and 2.2, and Tables 2.2 and 
2.3. A similar trend is consistently observed across all four fibrinogen concentrations analyzed.   
Cell proliferation assay also confirmed that gels synthesized with lower thrombin 
concentrations facilitated increased proliferation in comparison to stiffer substrates (Figure 2.4). 
A similar trend has also been reported with mesenchymal stem cells and fibroblasts grown in 
fibrin gels [49,50]. Studies using neural stem cells showed that when plated in 3D hydrogel 
cultures, there was a significant increase in proliferation as the stiffness of the scaffolds 
decreased [51]. Similar results were obtained for neural cells in 2D matrices with varying 
elasticity [25]. 
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Analysis of differentiation patterning of the cells cultured on the substrates revealed that 
while mesoderm and ectoderm remain relatively insensitive to changes in substrate physical 
properties, the endoderm markers elicit quite a strong response. More specifically, substrates in 
the range of 13Pa show strongest preferential upregulation of the endoderm markers under both 
2D and 3D culture configurations. The overall effect of the substrate, however, was more 
pronounced in 2D than in 3D cultures. At this point we would like to note that a similar study has 
been recently reported, however, the mentioned study used substrates with stiffness ranges that 
were four orders of magnitude higher, and their results were targeted towards osteogenic 
differentiation [30]. While evaluating the effect of the substrate composition, it was observed 
that for a fixed fibrinogen concentration, cells in softer gels are preferentially up-regulating 
endoderm related markers as compared to more cross-linked counterparts. Figures 2.6 and 2.7 
are extreme representative case study for fibrinogen concentration of 1 mg/ml and 8mg/ml while 
similar analysis on substrates of different fibrinogen concentrations consistently exhibited a 
similar trend of softer substrates leading to a stronger upregulation of endoderm related markers. 
Notwithstanding the variability in the extent of the particular effect, overall there was remarkable 
consistency in preferential upregulation of endodermal expression in less crosslinked substrates 
for both two- and three-dimensional culture configurations.  For 2D configuration, the ESCs 
cultured on 0.25X showed stronger upregulation compared to 1X, while the difference between 
1X and 2X is more subtle. The three dimensional culture overall shows a clearer trend of higher 
upregulation with softer substrates.  
A careful observation of the gels synthesized with lower thrombin concentrations show 
that even though no mesoderm markers exhibit significant upregulation, in some cases FGF8 is 
quite strongly upregulated. An explanation can be that FGFs, apart from being a mesodermal 
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marker, also plays a role in the endothelial development and are important angiogenic 
factors [52,53]. The upregulation of these markers can probably be attributed to differentiation 
into endothelial cells, explained by the fact that softer matrices result in larger cell clusters. 
Larger cell clusters results in insufficient transport of nutrients and oxygen to the center of the 
structures, which results in hypoxia and may trigger the creation of blood vessels, resulting in 
upregulation of FGF markers.  
Overall we consistently observe that for a particular fibrinogen concentration, gels 
obtained at lower thrombin concentrations favor endodermal differentiation of the cultured ESC. 
As revealed by the microstructural characterization of the gels, increasing the concentration of 
thrombin results in a dense network of thinner fibers which are less bundled (Figure 2.2). Such 
microstructural features manifest in increased substrate stiffness as a result of increased cross-
linking for the same fibrinogen concentration (Table 2.2). Based on the mechanical 
characteristics of the gel and the biological characterization of the cells on the fibrin substrates, it 
is reasonable to suggest without any uncertainty that lower substrate stiffness values 
preferentially favor ESC differentiation towards the endodermal lineage.  
Even though substrate stiffness is clearly playing an important role in cellular lineage 
commitment, it is certainly not the only factor, as revealed in Figure (2.10). Comparison of two 
substrates of varying fibrinogen concentration and fibrinogen to thrombin ratios but comparable 
substrate stiffness revealed that mesoderm and ectoderm markers were almost invariant under 
these two conditions, indicating these germ layers to be insensitive to the substrate properties at 
the initial stage of differentiation and within the substrate ranges presented in this study.  
Endoderm layer however varied significantly between these conditions, which establish that 
substrate stiffness, although important, is not the sole player in the process of germ layer 
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commitment. Careful analysis of the substrate micorstructural features revealed that even though 
the macroscopic stiffness properties are similar, the gels differ substantially in their 
microstructural features. These results warrant a more detailed analysis of the effect of substrate 
microstructural features on differentiation, which are currently being investigated by the authors. 
It is important to note that there is variability in the results obtained from different experiments 
as observed by the error bars attributed to population heterogeneity and variable response to 
global inductive cues [54,55]. However, despite the variability, all experiments consistently 
showed the similar trend of softer substrates preferentially favoring differentiation towards 
endodermal lineage.   
 
Figure 2.10: Comparison between substrates of same stiffness but different composition.  
 1 mg/ml fibrinogen obtained at F/T crosslinking ratio of 1x and fibrinogen concentration of 2 mg/ml 
obtained at F/T crosslinking ratio of 0.25x. Figure shows expression of most markers to be equivalent in both 
groups except for that of endoderm markers. Results normalized to 1 mg/ml fibrinogen 1x crosslinking ratio 
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This paper presents a thorough analysis of the effects of varying substrate mechanical 
properties on the embryonic stem cell proliferation and differentiation potential. The mechanical 
properties of the fibrin substrate are varied by systematically altering (i) the fibrinogen 
concentration and (ii) the thrombin concentration. SEM analysis of the synthesized gels illustrate 
the variation of microscopic gel microstructure, such as the fiber thickness, porosity and the 
overall effective area of fibrin strand available for cell anchorage as a result of altered fibrinogen 
and thrombin concentrations . Detailed mechanical characterization of the different substrates 
reveals that variation of substrate concentration or cross-linking results in substantial modulation 
of the substrate stiffness.  
Analysis of the ESC cultured on different substrate conditions clearly illustrate the strong 
influence which substrate mechanical properties assert on cellular proliferation and 
differentiation potential. Overall, the ESCs cultured on softer substrates, as a result of lower 
thrombin concentrations, were found to be more conducive to proliferation as well as 
differentiation. For both the 2-dimensional and 3-dimensional culture configurations analyzed in 
this work, the substrates with lower thrombin concentrations elicited a somewhat elevated 
expression level of most of the gene expression markers tested. However, the level of up-
regulation strongly depended on the specific germ layer. It was consistently observed that 
differential expression of endodermal markers are the strongest in gels obtained with lower 
cross-linking compared to highly cross-linked gels, an effect which was further accentuated in 3-
dimensional culture as compared to 2-dimensional culture. The presented results are indicative of 
the fact that lower substrate stiffness values are favoring the preferential differentiation of the 
ESCs towards endodermal lineage. However, substrate stiffness is not the sole player controlling 
differentiation, which is probably dependant on both gel microstructure and chemical 
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composition. Furthermore, among the germ layers tested, early mesoderm and ectoderm layers 
were found to be less responsive to substrate properties.   
 
2.4 MATERIALS AND METHODS 
2.4.1 Gel synthesis 
Soft fibrin hydrogels comprising 1, 2, 4, and 8 mg/ml of fibrinogen, respectively, were 
synthesized. The fibrinogen to thrombin ratios of 10, 2.5, and 1.25 mg/U (fibrinogen/thrombin) 
were synthesized for each fibrinogen concentration as previously described [56] and shown in 
Table 2.1. For convenience these ratios are referred to as 0.25X, 1X, and 2X respectively, 
corresponding to increased cross linking with increased thrombin concentration throughout the 
text. The fibrinogen to thrombin ratio, rather than simply either the fibrinogen or the thrombin 
concentration, was altered in order to ensure that a wide of a range of stiffness values could be 
studied for the fibrinogen concentrations chosen.  This was systematically done to ensure a 
complete range of low, medium and high concentrations of fibrinogen and thrombin, respectively 
as outlined in Table 2.1, 1 mg/ml representing a low fibrinogen concentration and 8mg/ml 
correspondingly representing a high fibrinogen concentration. Thrombin concentrations were 
selected to represent three F/T ratios of low (1.25), medium (2.5) and high (10) corresponding to 
low,  medium and high units of Thrombin. 
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2.4.2 Rheology measurments 
Gel discs of 35 mm diameter, prepared as described for 2D gel synthesis, were deposited 
onto glass slides which were pre-rinsed with DI water. The samples were then allowed to gel 
fully at 4 ˚C. After complete gelation, they were fully immersed in the same media used for 
differentiation studies. The glass slides were then secured to the Peltier cell of a TA Instruments 
AR2000 stress-controlled rheometer, which was kept at 37 ˚C throughout the measurements. 
A frequency sweep was then performed, using a 25 mm stainless steel in parallel plate 
geometry with sandpaper glued to the plate to avoid slippage.  The samples were subjected to an 
oscillatory strain described by equation (1), where  is the amplitude of the oscillatory strain (5%), 
f is the frequency and t is the time. Frequencies employed ranged from 0.1 to 100 rad/s. 
γ = γ o(2πft) (1) 
The stress required to achieve the specified strain was measured and the components of 
the complex modulus, the storage (G’), and loss (G’’) moduli were accordingly determined. 
2.4.3 Scanning electron microscopy (SEM) 
The fibrin gel microstructure was analyzed using SEM. The gels were prepared for SEM 
analysis as described previously in the 2D gel synthesis section above.  Preparation of samples 
was performed as previously described [56]. SEM images were collected using a Philips XL30 
field emission gun SEM (FEI Company). Further image analysis was then performed using the 
ImageJ software (acquired from http://rsbweb.nih.gov/ij/). 
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2.4.4 aintenance and differentiation  of ES cells 
Murine ESD3 cells were cultured according to previously published methods [57].    
2.4.5 Cell culture in 2D 
For differentiation of the ESCs on fibrin substrate, the cells were tripsynized, washed and 
re-plated in appropriate configurations. For the 2D culture 30,000 cells in 200ul media were 
plated on top of the pre-formed fibrin gels prepared on wells of 48 well plates and polymerized 
overnight at 4oC temperature.   
2.4.6 Cell culture in 3D 
For 3D cell culture format 100,000 cells were re-suspended in the fibrinogen solution 
before adding thrombin and plated on wells of 48 well plates. The gel with the entrapped cells 
was then allowed to polymerize for one hour at a temperature of 40C , after which the culture 
media was added and subsequently the culture was incubated. For both cases, the cells were 
maintained in DMEM medium (Invitrogen) supplemented with 10% FBS, 4mM L-glutamine 
(Cambrex) and 100U/ml penicillin, with media being changed every day. As control embryoid 
bodies were formed in rotary culture by adding 100,000 cells in ultra low attachment 35mm 
dishes with same media described above. The dishes were placed in a rotator in the incubation 
and maintained at constant speed of 40 RMP  
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2.4.7 QRT-PCR Analysis  
The mouse ESC (ESD3) cultured in the two- or three-dimensional configurations were 
harvested by trypsin after five days of culture and RNA was extracted using the NucleoSpin kit 
according to the manufacturer’s protocol. The sample absorbance at 280nm and 260nm was 
measured using a BioRad Smart Spec spectrophotometer to obtain RNA concentration and 
quality. Reverse transcription was performed using ImProm II Promega reverse transcription kit 
following the manufacturer’s recommendation. qRT-PCR analysis was performed for 
pluripotency and early germ layer markers using the primers listed in Appendix Table 1. Each 
sample was then run in replicates, and average values were accordingly used for analysis.  
2.4.8 Cell proliferation assay  
The proliferative potential of ES cells was analyzed using the Alamar Blue assay. For the 
two dimensional culture, 15,000 ESD3 cells were plated on fibrin gels of different 
configurations. 24 hours after plating, the culture media was replaced by fresh media containing 
10% Alamar blue and incubated for 4 hours. Fluorescence reading was obtained from a multi-
well reader (BioTek Synergy 2, Winooski, VT) at an excitation wavelength of 570nm and 
emission wavelength of 585nm according to the manufacturer’s instructions. Results were 
normalized with respect to the values obtained for the gels with the highest thrombin 
concentration, or most cross-linked (2X) condition. 
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2.4.9 Immunohistochemical analysis 
Staining was performed on differentiated cells. The fibrin gels containing cells in 3D 
format were formed on cover-slips in wells of a 24 well plate. Staining was performed following 
the company recommendations .The antibodies used were AFP goat polyclonal antibody and 
SOX17 rabbit polyclonal antibody (Santa Cruz). The secondary antibodies used were donkey 
anti-rabbit IgG Texas Red (Santa Cruz) and Alexa Fluor® 488 donkey anti-goat IgG 
(Invitrogen). Confocal images were taken using an Olympus Fluoview 1000 system. 
2.4.10 Statistical analysis  
Each experiment was performed twice with duplicates each time. Average and standard 
error were found and Student t-test was performed for significance and correspondingly, reported 
in the results section.  
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3.0  POTENTIAL FOR PANCREATIC MATURATION OF DIFFERENTIATING 
HUMAN EMBRYONIC STEM CELLS IS SENSITIVE TO SPECIFIC PATHWAY OF 
DEFINITIVE ENDODERM COMMITMENT 
3.1 INTRODUCTION 
Diabetes affect over 20 million people in the US [19]. In diabetic patients the body is 
unable to produce or properly use insulin. The most common treatment for type I diabetes 
consists of exogenous insulin supply. Other treatment alternatives include transplantation of 
cadaveric pancreas or isolated pancreatic islets [20], but the main limitations remains in the lack 
of available donor tissue.  hESC have been suggested as an alternative transplantable cell source 
for treatment of diabetes [58]. However exploitation of the full potential of hESCs requires a 
robust protocol for generation of mature and functional cell types. Pancreatic differentiation of 
hESCs has received considerable attention over the last decade. While there has been some 
success in deriving insulin (INS) positive cells from hESC, typically the differentiated cells are 
limited in yield and functionality [59]. Most differentiation protocols involve a stage-wise 
directed differentiation strategy that mimics stages of pancreatic organogenesis by modulating 
pathways known to be involved in pancreatic development [58]. The first critical stage of 
pancreatic differentiation is the commitment to definitive endoderm (DE). Studies over the last 
decade have established multiple alternate pathways for DE induction of hESCs. While all these 
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alternate routes yield efficient DE, it is not obvious how sensitive pancreatic maturation will be 
to such early pathways of DE induction. Thus, the method of DE induction remains somewhat 
arbitrary, being assessed only by the presence of DE markers and not by its potential for 
pancreatic maturation. 
In this work we are addressing this issue by evaluating the sensitivity of late stage 
pancreatic maturation on initial pathways of DE induction. We induced DE differentiation of 
hESCs by activation of the Nodal pathway through Activin A, in combination with modulation 
of one of the following pathways: WNT, BMP, PI3K and FGF. All of these pathways have been 
identified as key players at multiple stages of pancreatic development. Activin A, a TGF-β 
family protein has been long identified to mimic nodal, which results in mesoderm and DE 
formation [60]. FGF plays critical roles in several stages of pancreatic development. In the 
ventral pancreatic endoderm, FGF signaling comes from the adjacent endothelial mesoderm and 
at high concentrations specifies hepatic development at the expense of pancreatic 
differentiation [61]. Conversely, in the dorsal pancreatic endoderm, FGF signaling comes from 
the notochord and works as a sonic hedgehog (SHH) inhibitor, therefore inducing expression of 
PDX1 and further pancreatic development [61]. Additionally, BMP4 signaling from the septum 
transversum acts synergistically with FGF2 to induce hepatic differentiation at the expense of 
ventral pancreas development [62]. However, BMP4 signaling has been found to act 
synergistically with Activin and FGF2 to promote mesendoderm differentiation in human 
pluripotent stem cells [63] and has been used in combination with Activin for DE induction in 
pancreatic differentiation studies [64,65]. Similarly, inhibition of WNT signaling by proximal 
mesoderm has been implicated in proper pancreatic and hepatic progression from the foregut 
[62]; while activation of WNT induces mesendoderm formation in pluripotent stem cells from 
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mouse and human sources [66-68]. Lastly, PI3K was first reported as a negative regulator of 
cellular differentiation, and its inhibition has more recently been linked to proper endoderm 
formation under high nodal signaling conditions [69]. Studies have also linked PI3K suppression 
at later stages with proper endocrine specification [70]. 
Due to the high complexity of these pathways and their role in pancreatic progression, a 
more thorough analysis of their effects is needed. The aim of this study is to compare previously 
identified pathways of DE induction, analyze their pancreatic potential, compare differentiation 
of these derivatives with existing reports on in-vivo pancreatic organogenesis and identify 
markers that can be useful indicators of pancreatic differentiation at early stages of the 
differentiation program 
3.2 RESULTS 
3.2.1 Pancreatic differentiation of hESC 
A multi-stage directed differentiation protocol was used to induce the hESCs to 
pancreatic lineage (Figure 3.1). The first step was to induce DE through multiple alternate 
pathways, which was achieved by exposure to Activin in combination with one of the four other 
growth factors and molecules that modulate alternate pathways for DE induction. 
While Activin alone can induce DE, it is typically combined with different molecules to 
increase the efficiency of induction. In pancreatic differentiation studies, DE is most commonly 
achieved by combination of Activin A with WNT3A [71], BMP4[64], PI3K inhibitor[72] or 
FGF2[73]. 
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After 4 days of DE induction, Activin A and other inducers were removed and all groups 
were exposed to the same subsequent signals as follows (Figure 3.1): for pancreatic progenitor 
(PP) induction Cyclopamine was added alone for two days and in combination with retinoic acid 
for two additional days; cells were then exposed to nicotinamide alone for 2 days and 
nicotinamide and DAPT for up to one week for the maturation stage. 
 
Figure 3.1: Multi-stage Differentiation System. 
 (A) Schematic representation of multi-stage differentiation system. Detailed media formulation found in 
Supp table 1. DE was induced by modulation of nodal pathway simultaneously with one of four alternate 
pathways. PP was achieved by SHH inhibition along with retinol signaling. Maturation was induced by notch 
inhibition. Differentiation using WNT3A (B), BMP4 (C), PI3KI (D) or FGF2 (E) at DE stage. ICC pictures 
show nuclear staining of SOX17 (green) and Flow cytometry shows yield of FOXA2 after DE induction, 
followed by nuclear PDX1 ICC pictures (purple) after PP induction and cytoplasmic C-Peptide ICC (red) 
expression yield as measured by flow cytometry after maturation. 
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3.2.2 Pancreatic maturation of hESCs is sensitive to initial pathway of endoderm 
induction 
Morphological examination of the matured cells exposed to alternate DE induction 
pathway revealed heterogeneous populations of cells in all conditions (Figure 3.2A), containing 
groups of cobblestone like cells indicative of endoderm morphology; however, PI3KI cells 
appeared to be larger than other groups. To determine if this was attributed to cell confluence, 
and to analyze the system more thoroughly, we studied proliferation, apoptosis and dynamics of 
cell cycle under different induction conditions. Cell death at DE stage was comparable for all 
conditions except PI3K inhibition, which elicited high cell death. Figure 2B represents the 
number of dead cells floating in the media. Number of cells that remained attached was also 
quantified and found to be roughly 10% for all groups except for PI3KI which showed 20% (data 
not shown). This is evident in Figure 3.2C which shows a drop in cell number in PI3KI-DE. 
However, cell cycle dynamics (Fig 3.2D-E) confirms a proliferative population, with similar 
dynamics between PI3KI and WNT3A condition. Analysis of the cell cycle clearly indicates a 
maturing population of cells, transitioning from a dominant S phase to a dominant G1 phase, 
representative of mature cells [21]. As expected, undifferentiated hESC (time = 0) have a short 
G1 phase as exhibited by a low sub-population (~27%) in the phase, with subsequent increase in 
G1 residence time with differentiation (Fig. 3.2D). While the residence times of the S and G2/M 
phases are not expected to significantly change with differentiation, the fraction of the population 
in these phases decreases to compensate for the increased G1 phase (Fig. 3.2E, F). In contrast 
with PI3KI and WNT3A condition, BMP4 and FGF2 treated cells elicited a slower overall cell 
cycle dynamics, which was however not reflected in the proliferation data (Fig 3.2C) showing an 
almost identical behavior between WNT3A, BMP4, and FGF2.  
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Figure 3.2: Cell proliferation, death and morphological analysis of the cells 
(A) DE induction showing heterogeneous populations under all conditions (Scale bar: 12.5µM), and (B) Cell 
death after 24h of DE treatment. Death was comparable in all groups, except for PI3KI which resulted in 
considerably higher death (C) Cell number at the end of each stage of differentiation shows an increase in cell 
number at the end of each stage, except for maturation stage, which only increased for PI3KI treated cells. 
(D-F) Cell cycle analysis of the differentiating cellular population under different conditions, as analyzed and 
quantified by flow cytometry. Shown is the fraction of the population in the G1 (D), S (E), and G2/M (F) 
phases of the cell cycle. Data are represented as mean +/- STDEV 
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In order to confirm differentiation after DE induction, immunocytochemistry (ICC) and 
flow cytometry for SOX17 and FOXA2 was performed for all groups after 4 days of treatment. 
Both transcription factors were found to be expressed in all groups (Fig 3.1A-D) with yield of 
FOXA2 positive cells ranging from 40-90%. qPCR was performed to examine expression of 
stage specific markers CXCR4, SOX17, FOXA2 and CER. As illustrated in Fig. 3.3A, 
upregulation of these markers was obtained under all differentiating conditions, with PI3KI 
consistently eliciting the highest upregulation achieving close to 50 fold increase in CXCR4, 400 
fold increase in SOX17, 10 fold increase in FOXA2 and 500 fold increase in CER.  
Upon pancreatic induction, all the induction conditions show expression of PP marker 
PDX1 by ICC (Fig 3.1A-D). This was further confirmed by qPCR for PDX1, which showed that 
with the exception of BMP4 all other conditions strongly expressed PDX1 (Fig. 3.3B). A notable 
increase of other PP markers were also observed, particularly ISL1. BMP4 treated cells, 
however, consistently showed either comparable or lower upregulation of PP markers than the 
other groups. BMP4 treated cells additionally showed downregulation of PAX6.  
At the last stage of differentiation, ICC and flow cytometry confirmed expression of 
C-peptide for all groups with yields ranging from 9-24% (Fig 3.1A-D). Detailed gene expression 
for mature β cell markers (Fig 3.3C) revealed the highest INS mRNA upregulation under 
WNT3A and FGF2 conditions both of them achieving over 10,000 fold increase compared to 
undifferentiated cells, with no statistical difference between them. While BMP4 condition 
showed the lowest (11 fold) upregulation of INS, it was the highest in upregulation of GLUC 
mRNA (Fig. 3.3C). 
The above analysis clearly indicates that initial pathway of endoderm induction plays a 
crucial role in subsequent maturation of the cells towards pancreatic lineage. 
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Figure 3.3: Stage Specific Marker Expression.   
 (A) DE specific markers after DE induction under all differentiation conditions. Upregulation was obtained 
for all groups with PI3KI consistently yielding highest expression. (B) PP specific markers after PP induction 
for all DE derivatives with upregulation obtained for most markers under all conditions, except for BMP4 
which consistently resulted in lowest upregulation. (C) Pancreatic hormone expression after maturation for 
all groups with WNT3A and FGF2 groups achieving highest upregulation of INS (p > 0.05), while BMP4 
obtained lowest INS upregulation but highest GLUC expression. Data are represented as mean +/- SEM 
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3.2.3 Alignment of in-vitro differentiation with in-vivo organogenesis  
Research over the last decade has established the advantage of directed differentiation of 
hESCs following the sequence of in-vivo development. Hence there is an increased emphasis on 
aligning the in-vitro differentiation dynamics to in-vivo organogenesis events. Accordingly, we 
analyzed the alternate pathways of DE induction and subsequent maturation in the light of 
differentiation dynamics. 
Pancreatic development can be broadly divided into 7 stages, each characterized by 
specific transcription factors: (1) Primitive gut endoderm (PGE) from which pancreas, lung, 
thyroid, thymus, parathyroid, and liver are derived[74], followed by (2) prospective pancreatic 
endoderm (PPE) containing prospective ductal, endocrine and exocrine pancreatic cells. The next 
step is the (3) pancreatic progenitor (PP) stage marked by the transient expression of PTF1 and is 
followed by appearance of (4) NGN3 expressing early endocrine progenitors (EEP) which 
develop into (5) endocrine progenitors (EP) from which all the islet cell types develop, including 
α, β, γ, δ or ε cells. From here disappearance of NGN3 expression marks emergence of (6) 
immature β- cells which mature into functional, (7) INS expressing β-cells[7]. To draw a parallel 
to our 3-stage differentiation protocol we combined some of the developmental stages as 
follows: DE stage includes endoderm, PGE, and PPE; PP stage includes PP and EEP induction; 
finally, the maturation stage includes EP induction, immature β- cells and β- cell maturation. 
Figure 4A illustrates a qualitative measure of the expression level of stage specific transcription 
factors across different stages of development as gathered from literature [7,74]. Figure 4 (B-E) 
presents parallel transcription factor dynamics for hESC differentiation under different DE 
induction conditions as observed in a representative sample with INS expression closest to the 
mean. For the purpose of this study, we defined presence the of a marker as a 10 fold or higher 
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upregulation as observed in qPCR in order to account for experimental error. Overall, all of the 
FGF2, WNT and PI3KI conditions were found to exhibit similar trends as in-vivo development, 
only with some minor differences. For example, PTF1 is known to be an early and transient 
marker of pancreatic commitment, preceding PDX1 expression.  While both FGF2 and WNT 
conditions show a gradual increase in PTF1, under PI3KI conditions PTF1 comes up very late 
even though PDX1 expression is detected much earlier, even at the DE stage. On the other hand 
PAX6, which is expressed early in α cells and later in the entire islet [75] and has been suggested 
to be a key component of glucagon secretion [76], is prominent in PI3KI conditions from an 
early stage (DE) and increases with maturation. BMP4 condition, however, was found to be an 
outlier, as it did not align with either in-vivo sequences or any of the other conditions. 
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Figure 3.4: Marker Progression. 
A representative sample (based on INS expression) for each group was analyzed and compared to in-vivo (A) 
pancreatic development [24] in order to identify which DE pathway modulation(s) lead to better resemblance 
to pancreatic organogenesis. Similarities can be observed when DE induction is achieved by modulation of (B) 
FGF2, (C) BMP4, (D) WNT3A and (E) PI3KI while we observed that marker progression greatly differs 
under BMP4 induction.  The different stages of pancreatic development were grouped to represent the 3 
stages of the differentiation protocol. Primitive gut endoderm (PGE) and prospective pancreatic endoderm 
(PPE) represent DE induction (light green)  pancreatic progenitor (PP) and early endocrine progenitors 
(EEP) represent PP induction (medium green) and endocrine progenitors (EP), immature β- cells, mature β- 
cells (MC) represent the maturation stage (dark green).  
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3.2.4 BMP4 induced DE cells exhibit a divergent maturation dynamics  
Analysis by hierarchical clustering: In order to resolve the differentiation dynamics 
further, we performed hierarchical clustering of 15 stage specific transcription factors measured 
over 4 time points under the 4 DE induction conditions. Figure 3.5A shows a heat map of 
transcription factor dynamics. . Hierarchical clustering of the transcription factor dynamics 
identified four clusters of TFs, of which the most striking was the one formed under BMP4 
induction (NKX2.2, PAX6, HNF6, PTF1, NKX6.1). These factors were rapidly down-regulated 
with differentiation induction, the highest expression being in the undifferentiated cells. It is 
important to note that the data is Fig 3.5A is presented as relative expression; hence even though 
the absolute gene expression for undifferentiated cells were the same under all conditions, the 
differences in the heatmap arises from the normalization.. The aforementioned cluster branched 
separately from all the remaining clusters indicating the difference in transcriptional activation 
following BMP4 treatment. Overall, many of the PP markers were higher at the DE stage under 
BMP4 treatment while the later markers were not upregulated upon maturation. On the other 
hand FGF2, WNT3A, PI3KI treatments followed the pancreatic organogenesis closely as shown 
by clusters 2 to 4. On closer inspection, it was found that 67% of the markers assayed for are 
regulated in a similar manner under FGF2 and WNT3A pathway modulation, representing the 
largest similarity between the pathways studied. PI3KI leads to 47% and 40% similarity with 
WNT3A and FGF2 respectively, and the 3 pathways regulate 33% of the genes in a similar way. 
BMP4 treatment results in the most dissimilar gene patterning, sharing only 7% similarity with  
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FGF2 and 20% with both WNTA and PI3KI. Additionally, the magnitude of upregulation of 
genes assayed for, including INS, was comparable for these FGF2 and WNT3A conditions at all 
stages of differentiation. Taken together, these results suggest similarity in pancreatic maturation 
stages when FGF and WNT pathways were modulated for initial endoderm differentiation.  
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Figure 3.5:  Transcription factor dynamics.  
(A) Heat map for the entire data set of genes and conditions illustrating marker progression throughout 
differentiation stages. BMP4 induction condition typically was found to cluster separately from the rest. 
Hierarchical clustering was performed on the mean centered and variance scaled data of transcription factor 
dynamics across all the four DE induction conditions. (B) Biplot of transcription factor dynamics assessed by 
principal component analysis on the mean data-set. The first component shows a demarcation of the 
undifferentiated and differentiated states. The second component divides the markers according to their 
expected appearance during in vivo differentiation. The PI3KI curve moves closer to the DE markers, BMP4 
curve does not perform well and the WNT3A and FGF2 curves show successful pancreatic maturation. 
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In the hierarchical clustering formulation each of the markers was treated separately 
under each induction condition giving rise to a total of 60 marker-condition pairs. However, in 
order to compare the dynamics of differentiation it will be advantageous to look at the dynamics 
in the same space of transcription factors. Hence, we projected each of the induction condition in 
the same space of the transcription factors using principal component analysis (PCA). However, 
PCA will extract new orthogonal directions from the original space which are combinations of 
these markers. 
Analysis by principal component analysis: PCA allows visualization of multidimensional 
data in a new orthogonal coordinate space of PCs and often the first few PCs explain most of the 
variation in the data. In our case, we found that the first two components explained 67% of the 
variation in the data which is significant for biological systems as the remaining can often be 
attributed to noise. Figure 5B shows a biplot where the time points for each of the four induction 
conditions are plotted in the PC space with the original variables i.e. TFs overlayed onto the plot. 
The first PC divides the region into the undifferentiated state (III) and differentiated state (I & 
IV). The second PC further splits it into early markers (I & II) and the late markers (IV). Ideally, 
to mimic pancreatic development, the cells must proceed from the III quadrant (undifferentiated 
state) to  IV (mature hormone expressing cells) via I (DE stage). Except BMP4, all the other 
induction methods closely follow this path. It is found that WNT3A and FGF2 follow similar 
paths ending up closer to the INS and GLUC axes while PI3KI deviates significantly. PI3KI 
treatment still favors the DE markers like SOX17 and FOXA2 and some late markers like PAX6,  
HLXB9 and PDX1 during the final stages. However, PI3KI derivatives fail to perform well with  
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respect to the important mature markers like INS and GLUC. BMP4 derivatives perform very 
poorly with respect to INS expression, although we see that they proceed to the GLUC axis 
during the final stages.  
Diverse analysis of the experimental data leads to a similar conclusion: BMP4 induction 
is less suitable for pancreatic β cell maturation. This is primarily because of low INS expression 
in the mature phenotype along with lack of timely upregulation of intermediate transcription 
factors known to be associated with β-cell development. However, a similar treatment condition 
resulted in high GLUC expression, perhaps indicating its suitability for α-cell maturation. 
3.2.5 K-means clustering of individual pathways reveal WNT3a to be more consistent 
with development 
Our next goal is to determine which of the remaining conditions are more suitable to 
drive pancreatic maturation. One way to assess this is to find representative TFs that show 
coherent expression dynamics. To address this question we scrutinized each of the pathways 
individually through K-means clustering of each induction condition.  As shown in Figure 6A, 
SOX17, FOXA2, HLXB9 were co-regulated under WNT3A, FGF2 and PI3KI conditions.  These 
markers indicate the DE and dorsal pancreatic endoderm. This combination of SOX17, FOXA2 
and HLXB9 was repeated in all the above induction conditions and therefore, indicating that each 
of these treatments is efficient for activating the primary DE transcriptional machinery but the 
later stage transcriptional activation is different. These markers were consistently expressed 
through all the differentiation stages. In addition, PI3KI and FGF2 clusters also contained ISL1. 
However, no other coherent cluster was obtained for the PI3KI condition indicating lower 
alignment with developmental dynamics towards the later stages of maturation. 
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Figure 3.6: Significant K-means clusters.  
Clusters obtained for each induction condition. (A) WNT3A (B) PI3KI (C) FGF2 and (D) BMP4. The k-
means clusters show close similarity of our induction conditions WNT3A and FGF2 with pancreatic 
organogenesis and PI3KI with DE commitment. The markers SOX17, FOXA2, HLXB9 are closely regulated 
under all the induction conditions. 
Additional clusters containing many later markers were obtained for WNT3A and FGF2 
as shown in Figure 6B. One among these was PTF1 and ISL1 under WNT3A which arise in the 
pancreatic precursor cells during the early bud-stage. Other late markers like PAX6, PDX1, 
MAFA, GLUC, INS, NGN3, HNF6, and NKX2.2 which are expressed in the NGN3+ cells 
maturing to the β cell stage [77] were also identified under WNT3A treatment. These later 
markers show continuous rise in expression across the stages. Therefore, it reinforces the 
observation that early WNT3A induced cells were found to closely shadow the in vivo 
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embryonic transcriptional dynamics. For FGF2, clusters containing small number of late markers 
were identified as shown in Figure 6B. Two groups were identified, one containing PTF1 and 
INS and the other containing HNF6, PAX6 and MAFA. However, FGF2 contained far less 
coherent markers at the later stages than WNT3A. 
The above analysis indicates that modulation of activin with WNT and FGF2 are likely 
routes to pancreatic β cells, although WNT pathway is identified to be the most suitable because 
of the co-regulation of important markers during each stage of the differentiation process. 
Furthermore, this comparison reveals that even though the expression of DE and PP markers are 
quite similar for all the induction conditions at the end of DE stage, they deviate significantly 
upon maturation. This is suggestive of cellular ‘memory’ of pathway of initial induction even 
after phenotypic maturation. 
3.2.6 PP markers, and not DE markers, are reliable predictors of islet maturation 
The above results establish that different pathways of endoderm induction have a 
significant influence on its mature phenotype and functionality. Another way of looking at it is 
that efficiency of endoderm commitment, as analyzed by current markers, is not indicative of an 
efficient pancreatic maturation. The next question thus is whether any of the early or 
intermediate stages can reveal the potential for cellular maturation to islet cell types. 
We addressed this by performing partial least squares regression (PLSR) analysis on the 
mean TF expression data, to identify which early TFs, if any, were predictors of INS expression. 
Here we are seeking the TFs that showed the most significant correlation to INS expression over 
all the time points of the differentiation trajectory. The correlation of each of the TFs with INS 
for each induction condition is represented in Figure 3.7 as associated regression coefficients. It 
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is found that most of the PP markers show high degree of correlation to INS expression while 
there is no significant dependence on the DE markers analyzed. None of the early DE markers 
analyzed show a positive correlation to INS across all the induction conditions. The intermediate 
PP stage markers like PTF1, PDX1, HNF6, NKX2.2, NKX6.1, NGN3 are better predictors of INS. 
Also, WNT3A and FGF2 conditions gave positive coefficients with most of the PP and mature 
markers indicating that these conditions are optimal for INS expression. It is also observed that 
under BMP4 and PI3KI, the markers NKX6.1, PTF1 and NGN3 gave strong positive correlations 
indicating that these markers are in fact strongly associated with INS even under low INS 
upregulation. In addition, we analyzed the expression of PP markers after DE induction and we 
found high expression of HLXB9, PTF1 and ISL1 at this early stage under some of the 
conditions for the selected sample. Interestingly, PTF1 resulted in high upregulation under FGF2 
and WNT3A, which resulted in highest INS upregulation. This observation combined with the 
fact that PTF1 expression is highly correlated to INS expression under many conditions from 
PLSR suggests that analysis of PTF1 expression after DE induction could be used as a 
determinant of pancreatic potential. 
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Figure 3.7: Predictors of INS expression. 
Partial least squares regression performed on the mean expression. Most PP markers show high degree of 
correlation to INS expression while there is no significant dependence on the DE markers. WNT3A and FGF2 
conditions gave positive coefficients with most of the PP and mature markers indicating that these conditions 
are optimal for INS expression. 
3.3 DISCUSSION  
This study analyzes and compares the potential of pancreatic maturation of DE 
derivatives, obtained from hESC following alternate pathways. Our primary goal was to 
determine if potential for pancreatic maturation was sensitive to the pathway of initial DE 
commitment. And if so, determine which pathway is most supportive of pancreatic maturation. 
We chose to analyze those DE induction pathways which have been most commonly 
reported in literature for pancreatic differentiation of pluripotent stem cells. There have been 
reports of successful DE induction following alternate routes, which have not been considered in 
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the current study. For example, identification of small molecules has shown great promise as a 
cost effective alternative to expensive growth factors. While these molecules have not been 
directly compared in our protocol, many of these molecules modulate similar pathways as 
discussed here. Some examples include 1m and CHIR99021 which act by inhibiting GSK3β 
through WNT3A [78,79]; and IDE1 and IDE2 which modulate nodal pathway through activation 
of TGF-β signaling pathway, similar to Activin [80]. In addition, we have recently reported the 
sensitivity of endoderm differentiation to substrate physical properties, when cultured on fibrin 
[81] and alginate gel [82]. However, the exact mechanism involved in such induction of 
differentiation through insoluble cues has not been elucidated yet. 
Importantly, we found that the yield of mature INS expressing cells was sensitive to the 
pathways for initial DE induction. Our analysis suggests that BMP4 signaling is not conducive 
for pancreatic β cell differentiation of hESCs. Even though other studies have used BMP4 to 
achieve DE differentiation with subsequent maturation to pancreatic lineage [63,64,83], in our 
studies BMP4 derived DE derivatives were found to exhibit a stronger potential for GLUC 
expression when subjected to our maturation protocol. Several reasons could be attributed to this 
difference in the results. It is important to highlight that while these studies also use BMP4 at 
early stages of differentiation there are obvious differences in the entire differentiation protocol. 
Phillips et al [63,83] reported the use of BMP4 in combination with activin in early stages of 
differentiation; however, in later stages they use FGF, IGF, HGF, VEGF, amongst other factors. 
Their differentiation protocol is based on pancreatic differentiation from adult pancreatic ductal 
cells, while our protocol is based on recapitulation of events present during in-vivo pancreatic 
organogenesis.  
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Earliest effect of BMP pathway modulation during pancreatic development occurs at 
early stages, where in combination with Activin and FGF2, BMP4 signaling specifies DE 
induction [63]. Also, at the earliest stages of differentiation, BMP4 accelerates the down-
regulation of pluripotency genes and up-regulation of mesendodermal genes like BRACH [65]. 
However, later effects of BMP4 are inhibitory of pancreatic differentiation and strong inducers 
of hepatic differentiation [62]. In our experiments we see BMP4 to consistently induce lowest 
upregulation of DE, PP and mature β cell markers which could indicate residual BMP4 signaling 
from DE induction even after removal of BMP4 from media. This is consistent with several 
pancreatic differentiation studies that use BMP4 at DE induction stage, but use noggin, a BMP 
pathway inhibitor, at later stages of differentiation [84,85]. From marker progression analysis 
(Figure 3.4) we see that in BMP4 treated cells, NGN3 peaks early during DE induction with 
maintenance throughout the PP stage and decreases during the maturation stage. A recent study 
has implicated temporal regulation of NGN3 as an important determinant of cell type 
specification with early expression favoring α cell induction [86]. In agreement with this, we also 
see BMP4 cells do express highest levels of GLUC, while exhibiting a very low upregulation of 
INS. These results link BMP4 signaling to differentiation of α-cells in vitro suggesting that DE 
specification signaling may prime cells to mature endoderm tissue types. 
In a parallel work we tested possible combinations of growth factors for inducing DE and 
found the combination of Activin, FGF2 and BMP4 to give a high up-regulation of SOX17 and 
CXCR4 compared to using FGF2 or BMP4 alone [87] (Appendix figure 4). Recent work by Yu 
et al. [88] gives an explanation for this effect, with FGF2 sustaining Nanog expression and 
helping the BMP4 induced differentiation to shift towards endoderm as opposed to extra 
embryonic lineages . In a previous study by Vallier et al., using Activin in combination with 
  65 
FGF2 and BMP4 resulted in similar differentiation into mesendoderm [89]. Based on this we 
decided to mature the endoderm cells derived under combination of FGF2 and BMP4 towards 
pancreatic maturation. However, the level of INS upregulation upon maturation remained 
comparable to that of BMP4 treatment alone (Appendix figure 5). Thus, FGF2+BMP4 under 
high Activin seems to work well for DE induction, but may not be optimal for further maturation 
to the pancreatic lineages. 
Our analysis further indicated modulation of WNT pathway to be most supportive of 
pancreatic maturation. Several studies establish WNT canonical pathway as a potent endoderm 
inducer and its presence has been shown to stimulate expression of endoderm markers [7,90,91] 
while inhibition of WNT pathways induces increase of cardiac markers [92].  WNT is therefore 
added during in-vitro differentiation of hESCs particularly during the initial stages of 
mesendoderm induction. Canonical WNT pathway is found to co-operate with the Activin 
(SMAD) signaling pathways for the expression of mesendoderm specific genes [93]. However, 
WNT signaling must be suppressed at the later stages during differentiation to the posterior 
foregut endoderm [94,95]. Our results show WNT3A DE derivatives to result in high INS 
expression levels and highest yield of C-Peptide positive cells. In agreement with this, in a 
previous study, Nostro et al. found that at low concentrations, increasing canonical WNT 
pathway activation at the endocrine development stage gave higher up-regulation of INS [85].  
In addition WNT3A, FGF2 shared most similarities in terms of gene expression patterns 
and magnitudes, suggesting similar transcriptional regulation. Also, the results of PCA showed 
that the trajectory of differentiation was very similar for these two conditions. Interestingly, both 
these conditions also lead to highest expression of INS mRNA levels with no statistical 
difference between them. While gene expression patterns were similar between WNT3A and 
  66 
FGF2, cell cycle analysis reveals substantial differences (Fig 3.2). The length of the G1 phase for 
WNT3A treated cells increased at a faster rate than for FGF2, as shown by the higher proportion 
of the population in the phase. This longer G1 phase time is indicative of a more mature 
phenotype [96]. Therefore, while both conditions give desirable mature gene expression, 
WNT3A is the preferred route for maturation based not only on gene expression but cell cycle 
behavior.   
The conclusion that WNT3A leads to better pancreatic differentiation potential is in 
agreement with a number of pancreatic differentiation studies that use WNT3A in combination 
with Activin A at the definitive endoderm stage and achieve better yield, insulin expression and 
functionality after in-vivo maturation that other pancreatic differentiation studies [97]. 
Finally, our results highlight the insufficiency in analyzing DE markers at the DE stage as 
an adequate representation of cellular maturation potential. In our experiments, PI3KI 
consistently showed highest upregulation and yield of DE markers at the end of the DE induction 
stage. However upon maturation, its potential for INS upregulation was lower than that of 
WNT3A and FGF2. Our correlation analysis also supported this observation, where we found the 
PP markers to correlate strongly with INS, but not the earlier DE markers. This indicates that 
analysis of PP markers is likely to give us information on the maturation potential of the 
differentiating cells, but analysis of the DE markers alone is unlikely to reveal such information. 
In addition, we suggest PTF1 expression analysis after DE induction to be a potential candidate 
to determine pancreatic potential. PTF1 expression showed a high degree of correlation to INS 
expression in our PLSR analysis. Consequently, PTF1 expression appeared early in conditions 
resembling pancreatic progression, where PTF1 expression appears at the prospective pancreatic 
endoderm stage. 
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3.4 MATERIALS AND METHODS 
3.4.1 hESC maintenance 
H1 hESC (WiCell) were maintained in feeder free conditions as previously 
described [16]. 
3.4.2 Pancreatic differentiation protocol  
Once hESC reached an average colony size of 1 mm in diameter, DE induction media 
was added for 4 days with media change every day. After 4 days media was replaced with PP 
(PP) media for 2 days with media change every day. After 2 days, all-Trans Retinoic acid was 
added to the PP media for 2 additional days with media change every day. Media was then 
replaced with maturation media. After 2 days DAPT was added to maturation media. Cells were 
maintained in this media for 1 week with media change every day. Media formulations found in 
Appendix table 2.  
3.4.3 Proliferation and cell death quantification 
On day 0 of the protocol, several wells were treated with accutase and starting cell 
density was estimated using a hemocytometer. 24 hours after initial DE media exposure, cell 
death was quantified by counting floating cells in the media and normalized with respect to 
starting cell density. Additionally, the remaining attached cells were harvested with accutase, 
stained with propidium iodide in PBS at 10ug/ml concentration and the number of dead cells (PI 
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positive) was quantified by flow cytometry. For quantification of cell number throughout the 
entire protocol, cells were exposed to alamar blue at day 0 according to manufacturer’s 
instruction for quantification of cell number. This procedure was repeated at the end of each 
stage of differentiation (days 4,8,15), and cell number was calculated according to as described 
in the product manual, using Day 0 values as control for each of the stages. 
3.4.4 Quantitative polymerase chain reaction 
qPCR was performed as previously described [17]. A list of the primers used can be 
found in the Appendix table 3. ΔCt values were calculated by substracting the respective Ct 
value for GAPDH from the Ct value of the marker(s) of interest.  ΔΔCt values were calculating 
by subtracting the ΔCt values for undifferentiated cells for the marker of interest from the ΔCt 
value for the same marker in each group. Relative expression was found by calculating2
-ΔΔCt
.  
3.4.5 Flow cytometry 
Flow cytometry was performed as previously described [98] . As a control for 
non-specific staining, cells were incubated in secondary antibody only. Cells analyzed using an 
Accuri C6 flow cytometry instrument. Antibodies and concentrations can be found in the 
supplementary table 3. For cell cycle analysis Cells were harvested and dissociated with 
Accutase, rinsed, centrifuged and resuspended in ice-cold 70% ethanol and fixed overnight in -
20°C. Cells were rinsed and suspended in DNA staining buffer (PBS+0.1% Triton-X+0.2 mg/mL 
DNAse-free RNAse+0.01 mg/mL/1 million cells propidum iodide) for 25 minutes at RT. Stained 
cells were then directly analyzed on an Accuri C6 flow cytometer, the output of which being a 
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histogram of the DNA content for the cellular population in each sample. To accurately 
determine the fractions of the cellular population in each phase of the cell cycle from these data,  
Modfit LT (Verity Software House) was applied to the DNA histograms. Modfit identifies the 
G1 and G2 peaks of DNA histograms acquired by flow cytometry, and fits established cell cycle 
models to these peaks in addition to the S phase “peak”. The area under the curve is calculated 
via this model, thereby obtaining relative proportions of each cell cycle phase within the 
population.   
3.4.6 Immunocytochemistry 
Cells were fixed using 4% parafolmaldehyde for 15 minutes at room temperature and 
permeabilized using 0.25% Triton X-100 (TX) for 15 minutes. Blocking was performed  in 10% 
donkey serum in 0.05% TX for 30 minutes followed by primary antibody incubation, which was 
performed overnight at 4°C in blocking buffer with primary antbodies. Secondary antibody 
incubation was performed for one hour at room temperature in the dark with appropriate 
antibodies diluted in blocking buffer. Nuclear staining was performed by incubation with 
Hoescht stain in PBS for 5 minutes. Pictures were taken using Olympus IX81 inverted 
microscope and Metamorph imaging software. 
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3.4.7 Statistical analysis 
Differentiation results are presented as averages of 6 separate independent experiments. 
Error bars represent SEM. Kriskal-Wallis test was used to determine statistical significant 
difference between the DE induction treatments. Additional Mann–Whitney U tests were used 
for post-hoc comparison with Bonferroni correction of the α.  
3.4.8 Mathematical analysis 
3.4.8.1 Principal component analysis (PCA) 
The gene expression data containing the dynamics of the differentiation markers across 
the four stages of differentiation and the four conditions was analyzed using PCA. The data was 
preprocessed by mean centering and variance scaling across each transcription factor. PCA was 
done on this matrix in MATLAB R2010 by using the princomp option. It was found that the first 
two PCs explained at least 67% of the variance in the data for all the PC plots in this paper. 
Therefore, two principal components were retained in the final analysis. 
3.4.8.2 Clustering techniques 
K-means clustering was used to identify TFs that showed similar patterns of expression 
across the four stages independently for each condition. MATLAB function kmeans was used 
alongwith the correlation distance. The quality of the resulting clusters was judged by the 
Silhouette value (Si). We selected a threshold of 0.6 for Si, and determined the number of 
clusters k which gave all Si values greater than 0.6. Hierarchical clustering was done on the 
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entire dataset (all conditions together) to further classify the dynamics. We used the in-built 
Matlab functions pdist and linkage to perform the analysis on the mean expression data and the 
results were represented as a clustergram. We also tested the tree generated using different 
linkage measures and found all the trees to be similar with the cophenetic correlation coefficient 
greater than 0.9. 
3.4.8.3 Partial least squares regression (PLSR) 
We performed PLSR to find which of the earlier markers showed the highest correlation 
with INS up-regulation. The matrix, X, was generated as described in PCA. INS was chosen as 
the output, Y, and the remaining transcription factors acted as the predictors. We used the 
plsregress option from MATLAB which uses the SIMPS algorithm.  The data was mean centered 
and variance scaled. For the PLSR plot in Figure 2.7, the R2 values were above 0.995. 
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4.0  ENDOTHELIAL CELL MEDIATED MATURATION OF HUMAN EMBRYONIC 
STEM CELLS TOWARDS PANCREATIC ISLET CELL TYPES 
4.1 INTRODUCTION 
ESC are pluripotent cells that can be propagated in an undifferentiated state indefinitely 
making them a desirable source of cells for transplantation [99]. These cells can be guided to 
differentiate into virtually any cell and tissue type by provision of appropriate cues in a directed 
differentiation approach [100]. In terms of pancreas, directed differentiation consists of stage-
wise induction through events known to take place during pancreatic development, beginning 
with DE (DE) formation. This is typically achieved by modulation of the nodal pathway trough 
Activin A [101]or more recently, small molecules such as IDE1 and IDE2 [80]; Moreover, it has 
been demonstrated that supplementing nodal activity by modulating alternative pathways such as 
WNT3A [71] or PI3K inhibition [102] aids DE induction. DE induction is followed by PP (PP) 
commitment, marked by the appearance of PDX1 which is the diverging point between 
pancreatic progression and development of other DE  derived tissues [101]. It is well known that 
appearance of PDX1 is associated to sonic-hedhgog (SHH) inhibition during pancreatic 
development, therefore can be achieved through addition of cyclopamine in an in-vitro setting 
[103]. These PP are directed towards endocrine progenitors by addition of retinoic acid [104]. 
Finally, NGN3 expressing endocrine progenitors are matured towards beta cells trough different 
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mechanisms including notch inhibition, found during pancreatic development [105], and GLP-1 
activation which has been demonstrated to promote regeneration of beta cells through 
proliferation of already mature β cells and transdifferentiation of ductal PP cells [106].  
Several studies, including previous work in our lab, have used this information to develop 
directed differentiation protocols [71,102]. Many of these existing protocols result in high yield 
of PP cells. These cells also have the potential for functional maturation upon implantation in 
diabetic mice models [68]. However, maturing these cells into functional islet-like cells in an in-
vitro setting is yet to be demonstrated.  
Organogenesis is a complex and dynamic process involving signals from several parallel 
inputs including chemical, mechanical and from contact with neighboring cells. While there is an 
increasing trend to recapitulate the entire micro-environmental niche, most of the existing 
protocols use modulation of individual pathways through targeted molecules and growth 
factors [107].  In this report we are presenting an alternate strategy for achieving islet specific 
maturation of hESC derived PP cells. We hypothesize close contact with endothelial cells (EC) 
during final stages of hESC differentiation will induce islet specific maturation of the hESC 
derived PP cells. Several reasons lead to this hypothesis, including the fact that the pancreas and 
aorta develop in close proximity [7] and there is cross-talk between this cell types at several 
stages of development [108]; that the pancreas develops into a highly vascularized organ and that 
it has been shown that EC are capable of regulating mature β cell function [109-111].  
In this study we recapitulated cell-cell interactions between EC and hESC-derived PP in 
an in-vitro environment. We find that co-culture with different EC (but not fibroblast) results in 
pancreatic islet-specific differentiation of hESC-derived PP cells without additional chemical 
induction. The cells further demonstrated response to exogenous glucose levels by enhanced 
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C-peptide synthesis. Finally, analysis of a comprehensive database of signaling pathways 
suggests that our co-culture system aligned well with endocrine development and we suggest 
possible mechanisms involved in the observed phenomenon.  
4.2 RESULTS 
4.2.1 Multi-stage directed differentiation protocol 
hESC where propagated in hESC qualified matrigel coated dishes and maintained in 
mTeSR1 media until average colony diameter reached 1mm, at which point the hESCs were 
differentiated following a multi-stage directed differentiation protocol as described in Figure 
4.1A. The first stage involved DE induction by exposure to Activin A and inhibition of PI3K 
signaling by Wortmannin. These treatments lead to significant cell death, particularly on the first 
day. Surviving cells, however, rapidly proliferated with cell mass being recovered by day 4 of 
treatment. At the end of DE induction we observed upregulation of DE markers FOXA2, SOX17 
and CXCR4 by qPCR (Figure 4.1B). Protein expression was further confirmed by 
immunostaining, which showed strong nuclear expression of SOX17 (Figure 4.1C). Flow 
cytometry analysis of FOXA2 showed 90% of cells positive for FOXA2 stain (Figure 4.1D). 
Taken together, these results confirm DE induction by treatment with Activin A and PI3K 
inhibition.  
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Figure 4.1: Directed Differentiation Protocol.  
(A) Schematic representation of multi-stage differentiation system. DE was induced by modulation of nodal 
pathway simultaneously inhibition of PI3K. PP was achieved by SHH inhibition along with retinol signaling. 
Maturation was induced by endothelial cell co-culture. (B) qPCR result for DE  markers at the end of DE 
induction. (C) Representative flow cytometry for FOXA2 and (D) immunocytochemistry for SOX17. (E) 
qPCR result for PP  markers at the end of PP induction. (F) Representative flow cytometry and (G) 
immunocytochemistry for PDX1. Scale bar: 25µm 
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The second stage of our protocol consisted of PP induction by SHH inhibition by 
exposure to Cyclopamine followed by SHH inhibition and retinoid signaling. At the end of this 
stage, cells were harvested and analyzed for PP markers. qPCR analysis confirmed high 
upregulation of PP markers, particularly PDX1, HLXB9 and ISL1 (Figure 4.1E) which showed 
roughly 21,000, 800 and 9,500 fold upregulation over undifferentiated cells respectively.  PDX1 
expression was confirmed at the protein level both by immunocytochemistry and flow 
cytometry. Staining revealed strong nuclear expression of PDX1 in a large number of the cells 
(Figure 4.1F) and flow cytometry analysis for PDX1 confirmed 78% of the differentiated cells 
positive for PDX1 (Figure 4.1G). These results confirm proper differentiation into PP cells by 
exposure to cyclopamine and retinoic acid following DE induction.  
4.2.2 Endothelial cells mediate islet-specific maturation of hESC derived PP Cells 
The PP cells obtained by the protocol mentioned above were next subjected to the 
maturation protocol. The hESC derived PP cells were exposed to nicotinamide containing media 
for 2 days, after which rat heart microvascular endothelial cells (RHMVEC) were directly added 
to the differentiating population of hESCs to establish a contact co-culture configuration. Since a 
contact co-culture requires culturing both the differentiating hESCs and the endothelial cells 
(EC) in the same media, it is critical to develop a defined media that would support both hESC 
differentiation and sustain EC survival. RHMVEC are traditionally cultured in FBS containing 
media while our differentiation protocol in entirely serum-free. In order to maintain completely 
serum-free condition, the differentiation media was supplemented with growth factors that 
induce RHMVEC survival including EGF and crude FGF (EndoGro) (henceforth referred to as 
co-culture media). Despite this, RHMVEC survival was limited with considerable cell death 
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observed within 5 days of culture. Figure 4.2A shows DiI-Ac-LDL labeled RHMVEC in co-
culture with the hESC derived cells. It is observed that while many of the RHMVEC attach to the 
empty spots in the plate, a significant portion of the cells are in direct contact with the hESC 
derived PP cells. This was further confirmed by Immunostaining which shows Von Willerbrand 
factor (VWF) positive EC in direct contact with PDX1 positive PP cells (Figure 4.2B).  
 
Figure 4.2:  Endothelial Cell Induced Maturation co-culture with hESC-derived PP  
(A) Contact co-culture of hESC derived PP with Dil-ac-LDL labeled RHMVEC. EC are observed djacent 
(top) or in direct contact (Bottom) with hESC derived PP. (B) ICC shows VWF positive EC and PDX1 
positive hESC-derived PP cells in direct contact. (C)Maintenance of EC in serum free co-culture media leads 
to EC depletion attributed to absence of serum in media. (D) Before EC depletion ICC confirms expression of 
EC specific markers. 
Having established the co-culture system, we next evaluated the effect of co-culture on 
the differentiating population of hESC derived PP cells. As described above, the EC are added to 
the hESC after the PP stage and maintained in the co-culture media until the RHMVEC gets 
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depleted from the co-culture configuration (around 5 days). At that point the media was switched 
to regular hESC maturation media, without the EC supplements, and culture was continued for 5 
more days to allow for complete depletion of EC. Interestingly, we found that the RHMVEC 
survived longer when cultured in the presence of hESC-derived PP than when cultured alone 
(data not shown). Before complete depletion, RHMVEC were stained for EC specific markers 
VE Cadherin and VWF to confirm maintenance of EC phenotype (Figure 4.2C,D). The cells 
were harvested after complete EC depletion and PCR analysis showed over 200,000 fold 
upregulation of INS (Figure4.2E). In order to confirm that the observed effect on differentiation 
is mediated by the EC and not from the modified co-culture media, parallel control culture was 
maintained in co-culture media without the EC for 5 days and switched to maturation media at 
the same time as the co-culture group and maintained in this media for the remaining experiment. 
This control group showed a 68,000 fold upregulation of INS, hence confirming the positive role 
of EC in maturing hESCs to islet-like cells (Figure 4.2E). In the next step we compared the 
efficiency of differentiation mediated by EC with that of standard procedures of notch inhibition 
by DAPT treatment [57]. DAPT treatment for 5 days followed by maturation media for 5 
additional days resulted in comparable levels of INS up-regulation, without any significant 
difference (Figure 4.2E).  
4.2.3 Co-culture mediated maturation is Specific to endothelial cells  
Having confirmed the positive effect of RHMVEC in islet-specific maturation of hESC, 
we next wanted to investigate if the effect can be reproduced by other ECs as well. Human 
Umbilical Vein endothelial Cells (HUVEC) were our next choice of EC since it is a very well 
studied cell of human origin. HUVECs are more robust in culture and, unlike RHMVEC, 
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survived the entire maturation period, therefore after 5 days in co-culture media the HUVECs 
were thus labeled with DiO-Ac-LDL and sorted out prior to qPCR analysis. hESC-derived PP 
cells matured in contact with HUVEC showed almost 700,000 fold  upregulation of INS, 
resulting in over 3 fold higher INS gene expression compared to RHMVEC co-culture or notch 
inhibition by DAPT (Figure 4.3A). As a further precaution, the DiO-Ac-LDL positive sorted 
populations were also analyzed for INS gene expression, which was found to be undetectable. 
Hence this confirms that the hESCs are maturing into INS expressing cells when co-cultured 
with endothelial cells. 
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Figure 4.3: Endothelial cells mediate maturation of hESC-derived PPs.  
(A) qPCR for INS after maturation stage with DAPT, contact co-culture or co-culture media. Higher  
expression for cells matured by EC co-culture was observed. Co-Culture with (B) HUVEC and (C NIH3T3. 
Cells were sorted to isolate hESC derived cells and qPCR for INS and GLUC  was performed. qPCR results 
show that other endothelial cells also mediate insulin upregulation in hESC derived PP, while non-endothelial 
cells  do not. qPCR for the isolated HUVEC and NIH3T3  show no INS in either cell type confirming  that 
insulin upregulation comes from the hESC-derived cell population. qPCR results for cells matured varying 
EC density (D)or co-culture configurations (E). EC number positively correlates with insulin upregulation. 
INS expression is upregulated for all co-culture configurations but to a lower extent than contact co-culture. 
Transwell co-culture elicits higher upregulation than EC conditioned media, suggesting some signals may be 
short lived.  
Our next question was if the effect of the co-culture was specific to ECs or can be 
reproduced by any other cell type. To test this we performed a parallel co-culture with a 
fibroblast cell line (GFP-NIH-3T3). Like HUVEC, NIH-3T3 cells survived for the entirety of the 
maturation stage of the protocol, and the GFP positive fibroblast population was sorted out prior 
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to qPCR analysis. The negative hESC-derived population was analyzed for INS and GLUC 
expression, showed only a minimal 100 fold increase in INS expression (Figure 4.3B). Together, 
these results confirm that ECs have the potential to induce differentiation of hESC-PP cells into 
insulin expressing cells and that this effect is specific to EC and is not mediated by other cell 
types such as fibroblasts. 
4.2.4 EC mediated maturation of hESC-PP is augmented by direct contact between cells 
Having confirmed that co-culture with EC specifically governs islet-like maturation of 
the hESC-derived PP cells, we sought to investigate the effect of density of endothelial cell co-
culture on differentiation. Since HUVEC was mediating a stronger effect further experiments 
were performed with HUVEC (Figure 4.3C). ECs were added at a plating ratio of  1:1, 1:2  or 
1:10 with respect to hESC-derived PP cells in direct contact and the culture was continued as 
before. Analysis of the differentiated cells by qPCR after sorting out the ECs confirmed strong 
INS expression under all the co-culture ratios. The effect was, however, strongest with high 
density of co-culture with INS levels being progressively lower for lower co-culture densities 
(Figure 4.3C).  
In order to analyze the mechanism through which the endothelial cells are mediating hESC 
maturation, we investigated the effect of alternate co-culture configurations on hESC 
differentiation (figure 4.3D); namely, transwell co-culture in which the EC and the hESC-derived 
PP cells were plated on adjacent chambers separated by a semi-permeable membrane that allows 
diffusion of soluble signals, but prevents direct contact. Additionally we tested EC conditioned 
media where the co-culture media was added to HUVEC (maintaining the 1:1 ratio) for 24 hours 
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before being added to the hESC-Derived PP with media change in this manner every 24 hours. 
Both conditions were maintained for 7 days, at which point HUVEC viability started to decrease. 
qRT-PCR analysis for insulin gene expression under alternate configurations revealed highest 
up-regulation for contact co-culture, followed by 2 times lower expression in transwell and 5 
times lower in conditioned media culture.  This indicates that the maturation is mediated by cell-
cell contact along with possibly short-lived soluble factors. 
4.2.5 Characterization of cells matured by HUVEC  
Based on the above analysis, the hESC derived PP cells were co-cultured in direct contact 
with high density of HUVEC, and the differentiated cells were further characterized for relevant 
islet-specific maturation. Analysis by RT-PCR for relevant β-cell markers revealed (Figure 4.4A) 
particularly high upregulation of GLUT2 reaching 25,000 fold; NKX2.2, NKX6.1 and ISL-1 also 
achieved considerable upregulation of 200, 135 and 394 fold respectively. 
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Figure 4.4: Characterization of Endothelial Cell matured hESC-Derived Cells  
(A)qPCR for β- cell markers confirms maturation of hESC-derived PP by endothelial cell co-culture method 
(B)Characterization by ICC shows co-expression of C-Peptide and Proinsulin. Further ICC shows high co-
expression of Prosinulin and PDX1 and MAFA and C-Peptide. Scale bar: 12.5µm. (C) ICC for glucagon and 
c-peptide and somatostatin and proinsulin after EC contact co-culture show populations of poly-hormonal 
cells as well as populations of cells expressing c-peptide only. (D) qPCR for PDX1 and PTF1 expression show 
superior upregulation under co-culture maturation conditions. (E) Flow cytometry results indicate 29% of 
the cells are positive for c-peptide (F) Magpix was used to quantify intracellular c-peptide levels at low 
(2.5mM) and high (25mM) glucose levels. The results show approximately 6 fold increase in c-peptide upon 
high glucose stimulation. 
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Cells differentiated under this condition showed positive staining for PDX1, Proinsulin, 
C-Peptide and MAFA (Figure 4.4B). We examined whether the resulting cells were 
polyhormonal by immunocytochemistry (Figure 4.4C). Specifically we co-stained for Glucagon 
and C-Peptide and somatostatin and Proinsulin. For both cases we found populations of multiple-
hormone expressing cells; however we found a significant number of cells expressing insulin in 
the absence of other pancreatic hormones, representing fully mature cells. Staining for Amylase 
was found to be negative, suggesting absence of exocrine cells (not shown).  
Quantification by flow cytometry showed that about 29% of the cells were positive for C-
Peptide, compared to 15% obtained when using notch inhibition as illustrated in Figure 4.4D. 
The foremost functionality of β-cells is glucose responsive insulin release. Hence glucose 
responsiveness of the hESC derived cells was analyzed by exposing the cells to 2.5 mM (low) 
glucose or 25mM (high) glucose media for 4 hours and quantifying intracellular C-Peptide levels 
(Figure 4.4F). When stimulated in low glucose, the intracellular C-Peptide level was observed to 
be 2.5 pg/mg of total protein, while at high glucose concentrations these values increased to over 
16 pg/mg of total protein, representing an almost 7 fold increase over low-glucose condition. 
These results suggest that the hESC derived islet-like cells have the capability of modifying 
insulin biosynthesis in response to external glucose concentration. 
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4.2.6 Analysis of signaling pathways mediating EC-induced pancreatic maturation 
4.2.6.1 Correlation between markers associated with signaling pathways and pancreatic 
maturation 
In order to identify possible pathways that are differentially modulated by the endothelial 
cells, the gene expression profile at the end of maturation was analyzed using human signal 
transduction PCR pathway finder. The signal transduction genes were further supplemented with 
relevant pancreatic markers to form our complete dataset, as represented in Figure 4.5A. Figure 
4.5A presents the heatmap of –ΔΔCT values of the focus genes for two co-culture samples and 
one transwell sample labeled as samples 1, 2 and 3 respectively. Since, stem cell cultures show 
high degree of variability, we analyzed each sample independently without taking mean of the 
fold-changes. Using a threshold of 2-fold up- or down- regulation, the dataset was filtered to 
select the genes to be focused to further analysis. Among the 95 genes in the dataset, 37 were 
identified as the focus genes across all the three samples. These focus genes belonged to the 
following pathways: Hedgehog, JAK/STAT, NFκB, WNT, TGFβ, Hypoxia, PPAR, Notch 
and p53.  Next we wanted to identify any possible association between the signaling 
transcription factors and the pancreatic markers. Partial least squares regression (PLSR) analysis 
was performed with each pancreatic marker as the output and the signaling pathway genes as the 
input. We observed two groups of output markers based on the type of their relationship with the 
signaling genes as seen from the sign of the regression coefficient. The outputs INS, GCG, ISL1 
and NEUROG3 formed group 1 and NKX2-1, NKX6-1, NEUROD1 and GLUT2 formed group 2 
and these groups showed opposite relationships to the signaling genes. The regression 
coefficients for group 1 that contained our primary output of interest, INS, are presented in 
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Figure 4.5B. These regression coefficients denote the independent contribution by each signaling 
TF to the total output. As seen from the figure, the top five prime contributors were FCER2, 
ICAM1, WISP1, EPO and FABP1 while the remaining genes gave very small contributions. 
FCER2 (JAK1,3/STAT6), EPO (Hypoxia) and FABP1 (PPAR) showed a negative correlation 
while ICAM1 (NFκB) and WISP1 (WNT) elicited a positive correlation. The regression 
coefficients for group 2 are presented in Appendix Figure 4.6. 
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Figure 4.5: Quantitative analysis of signal transduction gene expression during maturation. 
(A) Heatmap of PCR gene expression at the end stage of maturation. Each sample is normalized to the 
respective control medium. A threshold of 2 fold upregulation/downregulation is used to filter the dataset and 
the –ΔΔCT values of the focus genes are presented here. The Y-axis contains signaling genes and the pancreas 
specific markers. Genes in red are up-regulated while those in green are down-regulated. It is seen that co-
culture sample 1 shows the highest INS levels. (B) PLSR coefficients indicating the correlation between the 
major pancreatic markers and signaling pathway genes. INS, GCG, ISL1 and NEUROG3 are taken as the 
outputs and the signaling pathway genes from (A) are taken as the inputs. The data matrix is log2 
transformed before regression analysis. The output markers show identical relationship to the signaling 
pathway molecules. (C) Upstream regulators of the focus genes in the dataset associated with deactivation of 
hypoxia mediated signaling in co-culture sample 1. 
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While this analysis is helpful in identifying independent relationships between each TF in 
the signaling pathway and the pancreatic markers, it is also informative to analyze the overall 
activity of pathways constituting these genes. Therefore, an in depth comparison of focus genes 
in the dataset to the literature was done using Ingenuity Pathway Analysis (IPA) database to infer 
network level information. 
4.2.6.2 Signaling pathways differentially regulated under co-culture configuration 
Network analysis was performed for the most representative sample (Sample 1) of co-
culture that gave the highest insulin up-regulation. Using the IPA database, the top networks 
associated with the genes in the dataset were identified and ranked according to the score values. 
Table 4.1 lists the identified networks with the corresponding scores and focus genes. The top 
network is associated with endocrine system development and contains 13 genes from the dataset 
(estimated probability of random gene placement = 10
-30
; i.e. score = 30). The remaining 
networks were associated with cell death and survival (score = 16) and cardiovascular system 
development (score = 14). Thus, based on gene expression, the co-culture dataset contains gene 
sets that contribute primarily to endocrine cell development. This network of endocrine cell 
development containing the relevant focus genes is presented in Appendix Figure 4.7. A 
biological functional analysis was also performed for the co-culture sample that further 
supported the network analysis. The significant functions are presented in Appendix Figure 4.8. 
Among the developmental functions, those associated with digestive system and endocrine 
system are again identified to be important. The molecular and cellular functions included 
cellular development, cell survival, cellular function and maintenance etc.  
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Table 4.1: Top networks in the dataset 
 
Using the IPA database, possible upstream regulators of global gene expression changes 
in the dataset were then identified. Table 4.2 lists the upstream regulators and their predicted 
activation status. The z-scores denote the significance associated with this predicted activation 
status as compared to a random association and scores with an absolute value greater than 2 are 
considered to be significant. Many of the top regulators are significantly activated in the co-
culture sample and only one pathway is significantly downregulated. Among the top upstream 
regulators, cyclic AMP is predicted to be activated based on the up-regulation of GATA3, 
CEBPD, CDKN1A, TNFSF10, SOCS3, SERPINE1 and down-regulation of IFNG, PTCH1, 
CCND1 and TNF. Similarly, hydrogen peroxide (H2O2) is also predicted to be activated based 
upon up-regulation of SERPINE1, BCL2A1, FOSL1, CDKN1A, ICAM1 and down-regulation of 
EPO, IFNG, TNF and CCND1. This is followed by butyric acid and angiopoietin 2. Among 
down-regulated pathways, only HNF1A upstream regulator was predicted to be significant. 
HNF1A and H2O2 together also form a connected system and interaction between these 
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molecules are shown in Figure 4.5C by an influence graph with the target genes from the dataset. 
Overall, the pathway analysis highlights ability of endothelial cells to mediate global gene 
expression patterns to follow pancreatic organogenesis and identifies the possible signaling 
pathways that are differentially regulated under the contact configuration. 
 
Table 4.2: Top upstream regulator of gene expression 
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4.3 DISCUSSION 
We have described a protocol for efficient differentiation of hESCs to insulin-producing 
cells using EC as mediators of PP cell maturation. We were able to confirm this effect to be EC 
specific by using EC from different sources as well as non-endothelial cells as controls. We also 
tried several co-culture configurations and we observed that contact co-culture leads to higher 
insulin expression suggesting that some of the signals are short-lived and/or require direct 
contact between the EC and hESC-derived PP. Characterization of the resulting cells showed 
higher yield of insulin expressing cells compared to standard method of notch inhibition and 
cells were found to express mature cell markers.  
Alternate strategies have been proposed for inducing DE for pancreatic maturation [Ref]. 
We initially attempted DE induction by activation of WNT pathway, which results in strong 
pancreatic progenitor differentiation. However there was less success with EC co-culture in this 
condition, primarily because the confluence hESC culture at the pancreatic progenitor stage 
interfered with EC attachment. On the other hand DE induction by Activin A and PI3KI as 
previously described [69,112] results in significant initial cell death. While the cells gradually 
recover with continued culture, still the culture is less confluent at the PP stage, thereby favoring 
EC attachment for contact co-culture.  
We performed the co-culture with three different cell-types: two endothelial cells and one 
non-endothelial cell. Our results confirmed the observed maturation effect to be specific to 
endothelial cell co-culture. While both the endothelial cells elicit a strong up-regulation of 
insulin in the differentiating hESCs, the effect was stronger in the human endothelial cell co-
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culture compared to the rate heart micro-vascular cells. This could imply that human EC in 
general are more supportive of human embryonic stem cell differentiation. However, we also 
observe that the HUVECs are more robust and survive longer in the co-culture configuration, 
compared to the RHMVEC cells, hence can potentially elicit a stronger effect on the cell 
maturation.  
At the end of our differentiation protocol, functionality was assessed my measuring 
intracellular C-peptide levels after incubation in low or high glucose media. While this method 
has not been widely used in other β cell differentiation studies, it is routinely used in β cell 
biology. The significance of it is that upon glucose stimulation the initial cell response consists 
of a series of events including increase of post-transcriptional modification of proinsulin into 
insulin to increase the available pool of intracellular insulin ready for release [113].  
We hypothesized that several mechanisms could mediate the observed phenomenon. One 
possibility is deposition of extracellular matrix by endothelial cells. This is in agreement with 
both developmental and differentiation studies. In terms of development it has been postulated 
that while pancreatic cells do not produce ECM, they produce VEGF which attracts endothelial 
cells. These endothelial cells produce ECM which aids with pancreatic progression trough 
activation of integrin mediated pathways [Cirulli, 2000; Nokolova, 2006]. In differentiation 
studies it has been observed that laminin-1 promotes differentiation of pancreatic progenitor cells 
into insulin expressing cells [Jiang, 1999]. Another possible mechanism by which endothelial 
cells mediate differentiation is restoration of normoxia, which has been suggested to favor beta 
cell differentiation [Heinis, 2010]. Related to this, release of nitric oxide from EC has effects that 
resemble normoxic conditions inhibition of endothelin-1 (Kourembanas, 1993), destabilization 
of HIF during hypoxic conditions, and interference with hypoxia signaling (Brune, 2007).  
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In order to investigate the mechanism through which the EC are mediating the maturation 
of hESC derived PP cells, we analyzed two additional co-culture configuration: transwell and 
conditioned media.  The contact co-culture was found to have the maximal effect, followed by 
transwell, while conditioned media had a positive but reduced effect on maturation.  We further 
analyzed these conditions using a PCR array for signaling pathway with the objective of 
identifying possible pathways through which ECs are mediating an effect. Further comparative 
analysis between the different co-culture configurations will also reveal the specific effect of 
contact co-culture. For example, C/EBPD was strongly up-regulated under contact co-culture, 
but not under transwell culture. C/EBPD, which has both anti-apoptotic and anti-inflammatory 
roles in pancreatic β-cells [31], has been found to be upregulated in hepatocytes cultured on 
laminin rich extracellular matrix [32]. Upregulation of C/EBPD in our co-culture configuration 
suggests the possibility of laminin secretion by EC in contact co-culture conditions. 
We further analyzed the array data to identify possible mechanisms mediating the 
maturation process and also a possible correlation between the beta cell maturation markers and 
signaling pathway molecules. PLSR analysis showed several genes that are highly correlated to 
insulin expression. Amongst them WISP1 which is expressed in the adult pancreas [114] and has 
been implicated in increase regenerative ability of beta cells [115]. Also, a high negative 
correlation was found with FABP1, which in the intestine has been found to be suppressed by 
expression of PDX1 [116]. Similarly EPO showed a strong negative correlation with insulin 
expression. EPO is produced and secreted during hypoxic conditions [ref], therefore suggesting a 
negative correlation between hypoxia and PP maturation.  
At this point, most of the analysis done consists of independent pathways and targets, 
however, we deemed important to analyze the overall activity of pathways constituting these 
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genes in the IPA database to infer network level information. Detailed pathway analysis revealed 
several of the differentially regulated genes to be from the signaling pathways belonging to 
pancreatic organogenesis. Secondly, biological functions associated with cellular survival were 
also identified to be important. Among the canonical pathways, those mediated by growth factors 
were strongly associated with the genes in our dataset. Among them, JAK/STAT has been 
recently implicated in the pancreatic maturation process and increased endocrine differentiation 
[117]. From the upstream analysis, IPA inferred many upstream regulators that could possibly be 
activated by endothelial specific signaling. Many of the downstream genes identified by IPA 
support the close association of H2O2 activation and HNF1A downregulation. For example, H2O2 
is found to inhibit EPO (associated with hypoxia) [118] and it is significantly downregulated in 
the coculture sample. EPO is also a downstream target of HNF1A [119,120]. Also, at later stages 
of maturation, HNF1A downregulation due to normoxia is found to favor β–cell differentiation 
[108]. This effect is due to the close association between endothelial cells and beta-cells during 
pancreatic organogenesis. 
In summary, we have developed a protocol for differentiation of hESC into insulin 
expressing cells that synthesize insulin in response to exogenous glucose levels. The last stage of 
our protocol recapitulates cell-cell interactions with endothelial cells as found during pancreatic 
development. Gene expression analysis showed a close resemblance to endocrine development, 
thus, by recapitulating cell-cell interaction aspects of the developmental niche we achieved a 
differentiation model that lines up with endocrine cell formation, and hence can be used as a 
model for β-cell development. 
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4.4 MATERIALS AND METHODS 
4.4.1 hESC maintenance 
H1 hESC (WiCell) were maintained in feeder free conditions as previously described 
[87]. EC at passages lower than 10 were maintained using MCDB-131 complete (VEC 
technologies). 
4.4.2 Differentiation 
Once hESC reached an average colony size of 1mm, DE induction media was added for 4 
days with media change every day. After 4 days media was replaced with PP media for 2 days 
with media change every day. After 2 days, all-Trans Retinoic acid was added to the PP media 
for 2 additional days with media change every day. Media was then replaced with maturation 
media for 2 days, after which EC were harvested and added to hESC-PP in serum containing 
MCDB-131 media overnight . The same media was added to both DAPT control and co-culture 
media controls. The next day co-culture media or DAPT control media were added with media 
change every day for up to 10 days. Media formulations found in Appendix table 2.  
4.4.3 Quantitative polymerase chain reaction 
qPCR was performed as previously described [81]. A list of the primers used can be 
found in the Appendix table 3. 
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4.4.4 Immunocytochemistry 
Cells were fixed using 4% parafolmaldehyde for 15 minutes at room temperature and 
permeabilized using 0.25% Triton X-100 (TX) for 15 minutes. Blocking was performed  in 10% 
donkey serum in 0.05% TX for 30 minutes followed by primary antibody incubation, which was 
performed overnight at 4°C in blocking buffer with primary antbodies. Secondary antibody 
incubation was performed for one hour at room temperature in the dark with appropriate 
antibodies diluted in blocking buffer. Nuclear staining was performed by incubation with 
Hoescht stain in PBS for 5 minutes. Pictures taken using Olympus IX81 inverted microscope and 
Metamorph imaging software. 
4.4.5 Flow cytometry 
Flow cytometry was performed as previously described [121] . As a control for non-
specific staining, cells were incubated in secondary antibody only. Cells analyzed using an 
Accuri C6 flow cytometry instrument. Antibodies and concentrations can be found in the 
Appendix table 4. 
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4.4.6 Quantification of intracellular C-Peptide 
Cells were exposed to low glucose (2.5mM) or high glucose (25mM) in Krebs ringer 
buffer for 2 hours. After glucose stimulation, cells were harvested and lysed using Bio-Plex 
lysing system according to manufacturer’s instructions. C-Peptide and glucagon were quantified 
with Bio-Plex Pro Human Diabetes kit following the product manual and analyzed using the 
Magpix Luminex system. 
4.4.7 Statistical analysis 
Every result is reported as an average of at least 3 independent experiments. Error bars 
correspond to standard error and p values were obtained using the Wilcoxon rank-sum test. 
4.4.8 Partial least squares regression (PLSR) 
We performed PLSR to find correlaton betwenn mature markers and the signaling 
pathways genes from the PCR array. The mature markers were chosen as the output, Y, and the 
signaling pathway genes as the predictors, X. The samples chosen contained both co-culture as 
well as transwell configurations and the data was normalized with respect to the control sample. 
From the signaling pathway genes, only those which showed greater than or equal to 2-fold up- 
or down-regulation were chosen. The data was log2 transformed and the analysis was performed 
using plsregress option from MATLAB (R2010b, Mathworks, Natick, MA). The quality of the 
regression was acceptable for most of the markers with R
2
 greater than 0.8. 
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4.4.9 Ingenuity pathway analysis (IPA) 
Focus genes were analysed using Ingenuity Pathway Analysis Tool (Version 7.6, 
Ingenuity® Systems) to identify the biological functions, signaling pathways and upstream 
regulators that were differentially regulated under endothelial cell co-culture. A threshold of 2-
fold was used for filtering. This resulted in set of focus genes that contained 42 eligible 
molecules for the co-culture sample from the 95 genes in the dataset. The top networks and the 
biological functions were analyzed for these focus genes.  The networks were assessed for their 
significance using the score function (z) with probability of random placement of the gene given 
as 10
-z
.  The biological functions were ranked using the significance score obtained from 
Benjamini-Hochberg (B-H) multiple testing correction method (values presented as -log(B-H p-
value)). The upstream regulators that may result in the gene expression changes observed in the 
dataset were tested using overlap p-values obtained from Fischer’s  Exact test. Also, the state of 
activation/inhibition was quantified using an activation z-score. The z-score signifies the 
consistentecy in the direction of increase or decrease of all the downstream genes associated with 
the upstream regulator. Z-score greater than 2 or less than -2 are significant. 
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5.0  OVERALL CONCLUSIONS AND FUTURE WORK 
5.1 CONCLUSIONS 
The studies presented in this dissertation merge together different components of the stem 
cell niche or native microenvironment to achieve embryonic stem cell differentiation into 
clinically relevant insulin expressing cells with the potential of being used as alternative 
therapies to organ transplantation for a number of pathologies of the pancreas, including type 1 
diabetes. We accomplish this by studying 1) the effects of substrate mechanical properties in 
early differentiation events, followed by 2) investigation of chemical modulation of pathways 
that induce DE specification and lastly, 3) exploitation of cell-cell interaction between hESC-
derived PPs and endothelial cells to achieve maturation of the former into functional insulin 
expressing cells. The results presented here highlight the different components of the stem cell 
niche which can modulate hESC fate commitment and functionality. Given the current 
limitations of pancreatic differentiation protocols, this leads us to conclude that all these aspects 
together and possibly more, need to be modulated and optimized in order to achieve a robust 
model for pancreatic differentiation. This can also be applied to differentiation of other stem cell 
types and into any cells or tissue.  
In our first study, ESC were cultured in fibrin gels of different compositions and 
therefore different mechanical and microstructural properties. In the chosen range of substrate 
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stiffness we found the ectoderm and mesoderm was insensitive to the substrate while the 
endoderm responded strongly to the different substrates. In this study we measured bulk stiffness 
of the substrates and concluded endoderm to be preferentially upregulated in softer gels. 
However, preliminary studies showed that substrates with similar stiffness, but differences in 
microstructure exhibit different differentiation behavior. This suggests that factors other than 
stiffness, contribute to differentiation.  
In a subsequent study by our group, the microstructural features of these substrates were 
analyzed in depth.  Nine different properties were isolated: fiber connectivity, node density, fiber 
aspect ratio, fiber diameter, fiber orientation index, pore orientation index, fiber length, pore size 
and bulk porosity. The correlation of each one of these properties with respect to differentiation 
was analyzed and fiber orientation was found to have the highest association to endoderm 
differentiation.  
That being said, the effect of substrate stiffness in embryonic stem cell differentiation 
cannot be completely disregarded. In a more recent study by our group [82] alginate was used at 
different cross-linking conditions to achieve different stiffness values. All gels were coated with 
fibronectin and ESCs were allowed to spontaneously differentiate on these substrates. Similar to 
our fibrin study, endoderm differentiation was more responsive to changes in substrate stiffness. 
Due to the continuous nature of these gels compared to the fiber structure of fibrin, 
microstructural characteristics were not considered an important factor, therefore it was 
concluded that stiffness was the sole mediator of differentiation in this system.  
Both studies raise the question of why is endoderm more sensitive to physical changes in 
the substrate. A very plausible explanation lies in the fact that in both systems the cells fail to 
spread but aggregate instead. As seen in the fibrin study, endoderm markers are preferentially 
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expressed at the periphery of the aggregates suggesting that these are the cells that are in direct 
contact with the extracellular environment, and therefore are more sensitive to changes in it. This 
leads one to question the sequence of events; do the cells in the periphery get signals from the 
extracellular environment that directs them into endoderm, or is there an intrinsic mechanism 
that directs the peripheral cells to become endoderm, which in turn respond to the extracellular 
environment due to their proximity to it? While in the studies reported here there is not enough 
data to support the answer to this, it has been seen that endoderm cells are also found in the 
periphery of embryoid bodies irrespective of the aggregate formation method (appendix 
figure 10). Since the aggregates seen in our studies are analogous to embryoid bodies, which are 
a well studied system for gastrulation, we can hypothesize that the peripheral cells become 
endodermal cells due to signals other than the substrate, but respond to it due to the proximity to 
it. The observed effect consists of upregulation of endoderm markers in those cells close to the 
periphery, and not expansion of DE trough proliferation, which by normalization with respect to 
cell number would show a decrease in other germ layer markers.  
Possible mechanism involved in this response still need to be investigated, however, we 
propose TWIST activation to be a possible mediator. TWIST is a gene involved in gastrulation 
of Drosphila embryos [122], found to be upregulated at the mesendoderm stage [123], 
responsive to mechanical stimuli [124]and regulated through nuclear translocation of β-catenin 
[125]. 
The second study presented here uses growth factors to direct differentiation of hESC. 
Previous work from our group [57] had developed a pancreatic differentiation protocol using 
mouse ESC. In order to adapt this protocol to hESC, the first step was proper differentiation into 
DE cells. A comprehensive literature review showed lack of uniformity in DE induction 
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mechanism amongst different groups and no evidence that supported one particular method over 
others. The importance of the study presented here lies in the comparison of widely used DE 
methods and the conclusion that modulation of pathways at this stage lead to cells with 
dissimilar pancreatic potential regardless of the fact that they all show expression of DE markers. 
Furthermore from the observation that even though at the DE stage we were obtaining “better” 
DE cells from PI3KI as judged by magnitude and yield of DE marker expression, this group 
failed to achieved good beta cell differentiation, we concluded stage specific marker expression 
to be an insufficient method of analysis and we suggest an alternative method for assessment of 
pancreatic potential.  
Regression analysis supported our experimental results suggesting that PP markers, 
instead of DE markers, are better predictors of pancreatic potential. While this statement appears 
to be intuitive, we suggest looking at PP marker expression at the DE stage, not only the PP 
stage. From the genes with highest correlation with insulin, we found PTF1 to be upregulated for 
both FGF2 and WNT3A induced cells immediately after DE induction. Its magnitude and 
expression patterns closely resemble those of FOXA2 and SOX17 up to the PP stage for those 
conditions which gave best insulin upregulation. This suggests that expression of FOXA2, 
SOX17 and PTF1 shortly after DE induction could be used as a predictor of pancreatic potential. 
In future studies a verification strategy should be developed for this observation. This can be 
achieved by creating cell lines with conditional expression of PTF1 so that its expression can be 
manipulated at desired stages of pancreatic development.  
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Last, we suggest that method of DE induction primes cells towards specific DE 
derivatives at later stages of differentiation protocols. This idea is once again supported by 
subsequent work in our laboratory [126] where a more detailed analysis of DE induction was 
performed by using a larger catalogue of DE markers and all possible combinations of growth 
factors (Appendix figure 4). It was observed that BMP4 conditions lead to down-regulation of 
CER and HNF6, both of which indicate foregut development, while FGF2 and WNT3 conditions 
have the opposite effect. This supports the idea that “priming” of potential occurs at the DE 
stage, with FGF2 and WNT3A priming cells towards forgut development, therefore this cells 
have higher potential of becoming foregut structures such as the pancreas.   
In the last study presented here, the effect of cell-cell interactions is studied by adding EC 
in direct contact with our hESC-derived PP cells to modulated maturation into insulin expressing 
cells. We were able to confirm this effect to be endothelial cell-specific by using EC from 
different sources as well as non-endothelial cells as controls. We also tried several co-culture 
configurations and we observed that contact co-culture leads to higher insulin expression 
suggesting that some of the signals are short-lived and/or require direct contact between the EC 
and hESC-derived PP. Investigation of possible mechanisms associated with this phenomenon 
was performed using qPCR arrays. From these arrays we found consistent expression patterns for 
several genes responsive to signal transduction pathways. Regression analysis was performed to 
find significant correlations between these genes and insulin expression resulting in 
identification of relevant pathways including the JAK/STAT pathway, hypoxia pathway, NFκβ, 
WNT and PPAR pathways. We then used IPA database to predict activation status of associated 
pathways which suggested activation of hydrogen peroxide pathway and inhibition of HNF1A 
pathway. Consistent with our regression analysis, this points to downregulation of hypoxia, or 
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restoration of normoxia as a possible mechanism trough which EC mediate maturation of hESC-
derived PP. This remains to be further examined, which can be achieved by manipulating oxygen 
tension in the culture conditions, with confirmation of our results consisting in recapitulation of 
our current observations at heightened oxygen tension in the absence of endothelial cells. 
5.2 FUTURE WORK 
In this study we separately evaluate the effect of mechanical, chemical and cell-cell 
interactions in differentiation of ESC into pancreatic cells. The aim of future studies is to 
combine these signals together to more closely mimic the complex developmental niche and 
develop a system for differentiation including ECM, growth factors and cross-talk between 
different cell types.  
Fibrin was picked as a scaffold in our first study for its biocompatibility and ability to be 
tuned into scaffolds with varying physical properties. Based on the observations from our first 
and second study, Activin A and WNT3A could be added to hESC encapsulated in soft fibrin 
gels. By doing this we would study the effects of synergistically using physical and chemical 
cues to achieve DE induction. Another advantage to this system is the formation of cell 
aggregates as seen in our fibrin study. It has been postulated that cell aggregates lead to 
improved differentiation, which has also been observed in studies done in our group. A possible 
limitation to this however arises from mass transport limitations to the cells at the core of these 
aggregates. McDevitt’s group has shown that embryonic stem cell can be formed into aggregates 
containing microspheres [127]. Studies by other groups [128] have successfully formed fibrin 
microbeads. By combining these observations, a possible solution to the mass transfer limitations 
  105 
of the previously suggested system is formation of stem cell aggregates containing fibrin 
microbeads with immobilized growth factors.  
At later stages of our protocol, endothelial cells can also be used in conjunction with 
fibrin. Fibrin scaffolds have been postulated as desired candidates for vascular tissue engineering 
because unlike other materials used for clinical implants, fibrin promotes endothelial cell 
adhesion and spreading [129].  A possible method is encapsulation of endothelial cells and 
embryonic stem cell derived PP cells into fibrin gels with immobilized growth factors that 
promote endothelial cell survival.  
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APPENDIX A 
SUPPLEMENTARY INFORMATION  
 
Appendix figure 1. qPCR results for cells plated on gels of 2 mg/ml fibrinogen and various thrombin 
ratios in 2D (A) and 3D (B) culture formats. Expression levels of ectoderm and mesoderm markers 
remained relatively constant for all crosslinking ratios. There was significant upregulation of endoderm 
markers AFP in the 2D culture and Hnf4 in the 3D culture for lower crosslinking groups. * p < 0.05 compared 
to highest stiffness values 
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Appendix figure 2. qPCR results for cells plated on gels of 4 mg/ml fibrinogen and various thrombin 
ratios in 2D(A) and 3D culture formats (B). Most striking difference of marker expression found in 
3D formats, where all endoderm markers were significantly upregulated in substrates of lower crosslinking 
ratios compared to highest crosslinking ratio. Fgfs were also upregulated, but no other mesoderm or 
ectoderm markers showed a significant difference. * p <0.05 compared to highest stiffness values 
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Appendix figure 3. SEM images of 1 mg/ml gels at 1x crosslinking ratio (A) and 2 mg/ml gels at 0.25x 
crosslinking value (B). Rheology measurements showed comparable stiffness ranges. However, 
microstructural analysis showed significant differences in characteristics, including node density, pore size 
distribution and fibre diameter 
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Appendix figure 4: DE induction using Activin A and all possible combinations of molecules used in 
chapter 3.  
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Appendix figure 5: Insulin expression after maturation stage for cells treated with activin with FGF2, 
BMP4 or both at DE stage 
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Appendix figure 6: PLSR regression coefficients for group 2 outputs, NKX2-2, NKX6-1, NEUROD1, 
GLUT2.  
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Appendix figure 7 : Top Network associated with endocrine system development as identified by the 
IPA on the co-culture dataset.  
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Appendix figure 8. Pathway Analysis for Coculture Sample.(A) Significant biological functions 
associated with the dataset above the threshold are presented here. Top: Developmental functions, 
bottom: Molecular and cellular functions. (B) Important canonical pathways associated with gene 
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Appendix figure 9: Comparison between Co-culture and Transwell samples. (A) Functions associated 
with development (B) Molecular and Cellular Functions  
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Appendix figure 10: Immunohistochemistry of embryoid body formed by hanging drop method 
showing peripheral expression of SOX17 
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Appendix table 1: Primers used for q-RT-PCR in chapter 2 
TISSUE NAME DIR SEQUENCE
L cagcagttggttggagca
R tgggagggtgagggactt
L aaggtcatccacggcaca
R tgggagtcatcgcttggt
L ggagaagtgggtggaggaa
R gctgattggcgatgtgag
L ctggactgcgaactggaga
R ttggatgggattggtggt
L aagaacggcaggaggatg
R gcgagtctgggtggatgta
L acggcaaaggcaaggact
R tgaagggcgggtagttga
L gcaccgcaccatcttca
R tcgcttctgtcgtctcca
L atccaaccagcccactga
R acaccacggaggaaatgg
L ctctggcgatgggtgttt
R aactggaagggtgggaca
L catcgtcaagcctccctct
R ccctcagcacacggtttt
L ggaggatgtggtggaggat
R ttcccgtctgctctggtt
L ttcaagcagtccgagcaa
R taggcacagcagagggatg
L atctggtctccgtccctga
R cgctccgaatggcacta
Ectoderm
Nestin
FGF5
BMP4
Mesoderm
Brachyury T 
FGF8
GSC
Endoderm
Sox 17
AFP
HNF4
Control B-Actin
PLURIPOTENCY
rex1
0ct4
sox2
 
 
Appendix table 2: Media formulations for pancreatic differentiation protocol used in chapter 3 
Stage 
Base 
Media 
Supplements Inducers Comments 
Definitive Endoderm DMEM/F12 
0.2% BSA 100ng/ml Activin A 
Day 0-4 
B27 *100ng/ml Fgf2 
  *100ng/ml Bmp4 
  *25ng/ml Wnt3a 
  *1μM Wortmannin 
Pancreatic Progenitor DMEM/F12 
0.2% BSA 0.2µM KAAD-Cyclopamine Day 4-8 
B27 2µM All-Trans Retinoic Acid Day 6-8 
Maturation DMEM/F12 
0.2% BSA 10mM Nicotinamide Day 8-End 
B27 30μM DAPT 
Day 10-
End 
25 μg/ml Insulin      
50 μg/ml Transferrin     
30nM Sodium Selenite     
     
** Either/or 
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Appendix table 3: q-RT-PCR primers used in Chapter 3 and 4 
Gene Primers Reference 
GAPDH 
ACGACCACTTTGTCAAGCTCATTTC D'Amour et al., 
2006 GCAGTGAGGGTCTCTCTCTTCCTCT 
SOX17 
CTCTGCCTCCTCCACGAA 
Osafune et al., 2008 
CAGAATCCAGACCTGCACAA 
CER 
ACAGTGCCCTTCAGCCAGACT D'Amour et al., 
2006 ACAACTACTTTTTCACAGCCTTCGT 
FOXA2 (Hnf3b) 
GGAGCGGTGAAGATGGAA 
Osafune et al., 2008 
TACGTGTTCATGCCGTTCAT 
CXCR4 
CACCGCATCTGGAGAACCA D'Amour et al., 
2006 GCCCATTTCCTCGGTGTAGTT 
PDX1 
AAGTCTACCAAAGCTCACGCG 
Kroon et al., 2008 
GTAGGCGCCGCCTGC 
PTF1 
GAAGGTCATCATCTGCCATCG D'Amour et al., 
2006 GGCCATAATCAGGGTCGCT 
NGN3 
CCTTACCCTTAGCACCA 
Kroon et al., 2008 
CCCTCTACTCCCCAGTCTCC 
HNF6 
TGTGGAAGTGGCTGCAGGA 
Zhang et al., 2009 
TGTGAAGACCAACCTGGGCT 
HLXB9 
CACCGCGGGCATGATC D'Amour et al., 
2006 ACTTCCCCAGGAGGTTCGA 
PAX4 
TCTCCTCCATCAACCGAGTC 
Zhang et al., 2009 
GAGCCACTATGGGGAGTGAG 
PAX6 
CGAATTCTGCAGGTGTCCAA 
Zhang et al., 2009 
ACAGACCCCCTCGGACAGTAAT 
NKX6-1 
AGACCCACTTTTTCCGGACA 
Zhang et al., 2009 
CCAACGAATAGGCCAAACGA 
NKX2-2 
GGCCTTCAGTACTCCCTGCA D'Amour et al., 
2006 GGGACTTGGAGCTTGAGTCCT 
ISL1 
GATCTATGTCACCTCGCAAGG 
Osafune et al., 2008 
TACAACCACCATTTCACTG 
MAFA 
CTTCAGCAAGGAGGAGGTCATC 
Zhang et al., 2009 
CTCGTATTTCTCCTTGTACAGGTCC 
SOMATOSTATIN 
CCCAGACTCCGTCAGTTTCT 
Zhang et al., 2009 
ATCATTCTCCGTCTGGTTGG 
GLUT2 
AGCTTTGCAGTTGGTGGAAT 
 Hui et al., 2001 
AATAAGAATGCCCGTGACGA 
INSULIN 
AAGAGGCCATCAAGCAGATCA D'Amour et al., 
2006 CAGGAGGCGCATCCACA 
GLUCAGON 
AGGCAGACCCACTCAGTGA 
Osafune et al., 2008 
AACAATGGCGACCTCTTCTG 
 
 
 
 
  118 
Appendix table 4: Antibodies used in Chapter 3 
Antibody Source Application Dilution 
FOXA2  Santa Cruz Biotechnologies sc-20692 Flow 1:500 
C-Peptide  Abcam ab14181 Flow/ICC 1:1000/1:500 
Alexafluor 488 or 647 Invitrogen Flow/ICC 1:1000/1:500 
SOX17  Santa Cruz Biotechnologies sc-17355 ICC 1:200 
PDX1  Santa Cruz Biotechnologies sc-14662, 1:200 ICC 1:200 
Hoescht stain Invitrogen ICC 1:1000 
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